AU2011272853A1

AU2011272853A1 - Heterocyclic compounds and their use as inhibitors of PI3K activity

Heterocyclic compounds and their use as inhibitors of PI3K activity Download PDF

Info

Publication number: AU2011272853A1
Authority: AU; Australia
Prior art keywords: nrara; alk; ora; 4alk; amino
Prior art date: 2010-07-01
Legal status : Abandoned

Application number

AU2011272853A

Other languages

English (en)

Inventor

Minna Hue Thanh Bui

Benjamin Fisher

Xiaolin Hao

Brian Lucas

Current Assignee

Amgen Inc

Original Assignee

Amgen Inc

Priority date

2010-07-01

Filing date

2011-06-30

Publication date

2013-01-10

2011-06-30 Application filed by Amgen Inc filed Critical Amgen Inc

2013-01-10 Publication of AU2011272853A1 publication Critical patent/AU2011272853A1/en

Status Abandoned legal-status Critical Current

Links

230000000694 effects Effects 0.000 title claims abstract description 23
239000003112 inhibitor Substances 0.000 title description 11
108091007960 PI3Ks Proteins 0.000 title description 6
150000002391 heterocyclic compounds Chemical class 0.000 title description 2
102000010400 1-phosphatidylinositol-3-kinase activity proteins Human genes 0.000 title 1
238000000034 method Methods 0.000 claims abstract description 82
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 19
230000002757 inflammatory effect Effects 0.000 claims abstract description 14
230000001404 mediated effect Effects 0.000 claims abstract description 13
208000023275 Autoimmune disease Diseases 0.000 claims abstract description 12
208000035475 disorder Diseases 0.000 claims abstract description 12
206010039073 rheumatoid arthritis Diseases 0.000 claims abstract description 11
206010028980 Neoplasm Diseases 0.000 claims abstract description 10
201000004681 Psoriasis Diseases 0.000 claims abstract description 8
201000008482 osteoarthritis Diseases 0.000 claims abstract description 8
201000000596 systemic lupus erythematosus Diseases 0.000 claims abstract description 7
230000001419 dependent effect Effects 0.000 claims abstract description 6
208000026935 allergic disease Diseases 0.000 claims abstract description 5
206010020751 Hypersensitivity Diseases 0.000 claims abstract description 4
230000004968 inflammatory condition Effects 0.000 claims abstract description 4
208000035186 Hemolytic Autoimmune Anemia Diseases 0.000 claims abstract description 3
206010020853 Hypertonic bladder Diseases 0.000 claims abstract description 3
206010021245 Idiopathic thrombocytopenic purpura Diseases 0.000 claims abstract description 3
208000034189 Sclerosis Diseases 0.000 claims abstract description 3
208000021386 Sjogren Syndrome Diseases 0.000 claims abstract description 3
208000031981 Thrombocytopenic Idiopathic Purpura Diseases 0.000 claims abstract description 3
208000002552 acute disseminated encephalomyelitis Diseases 0.000 claims abstract description 3
201000000448 autoimmune hemolytic anemia Diseases 0.000 claims abstract description 3
201000003710 autoimmune thrombocytopenic purpura Diseases 0.000 claims abstract description 3
230000001684 chronic effect Effects 0.000 claims abstract description 3
208000030533 eye disease Diseases 0.000 claims abstract description 3
230000009610 hypersensitivity Effects 0.000 claims abstract description 3
150000001875 compounds Chemical class 0.000 claims description 169
229910052739 hydrogen Inorganic materials 0.000 claims description 136
MPVDXIMFBOLMNW-UHFFFAOYSA-N chembl1615565 Chemical compound OC1=CC=C2C=C(S(O)(=O)=O)C=C(S(O)(=O)=O)C2=C1N=NC1=CC=CC=C1 MPVDXIMFBOLMNW-UHFFFAOYSA-N 0.000 claims description 132
125000005843 halogen group Chemical group 0.000 claims description 125
125000004093 cyano group Chemical group *C#N 0.000 claims description 87
-1 C 1 _4haloalk Chemical group 0.000 claims description 76
125000001424 substituent group Chemical group 0.000 claims description 66
229920006395 saturated elastomer Polymers 0.000 claims description 62
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 54
125000004429 atom Chemical group 0.000 claims description 36
229910052799 carbon Inorganic materials 0.000 claims description 36
125000002950 monocyclic group Chemical group 0.000 claims description 27
125000004432 carbon atom Chemical group C* 0.000 claims description 22
125000000464 thioxo group Chemical group S=* 0.000 claims description 22
150000003839 salts Chemical class 0.000 claims description 21
229910052757 nitrogen Inorganic materials 0.000 claims description 20
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 17
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 13
125000005842 heteroatom Chemical group 0.000 claims description 11
125000000623 heterocyclic group Chemical group 0.000 claims description 11
108010011222 cyclo(Arg-Pro) Proteins 0.000 claims description 10
206010002556 Ankylosing Spondylitis Diseases 0.000 claims description 7
201000001263 Psoriatic Arthritis Diseases 0.000 claims description 7
208000036824 Psoriatic arthropathy Diseases 0.000 claims description 7
208000027866 inflammatory disease Diseases 0.000 claims description 7
239000008194 pharmaceutical composition Substances 0.000 claims description 7
101100079984 Caenorhabditis elegans nhr-9 gene Proteins 0.000 claims description 6
239000003085 diluting agent Substances 0.000 claims description 5
229910052701 rubidium Inorganic materials 0.000 claims description 5
229910052760 oxygen Inorganic materials 0.000 claims description 3
229910052717 sulfur Inorganic materials 0.000 claims description 3
230000000172 allergic effect Effects 0.000 claims 1
208000010668 atopic eczema Diseases 0.000 claims 1
239000000203 mixture Substances 0.000 abstract description 57
210000003719 b-lymphocyte Anatomy 0.000 abstract description 24
210000001744 T-lymphocyte Anatomy 0.000 abstract description 9
206010006187 Breast cancer Diseases 0.000 abstract description 6
208000026310 Breast neoplasm Diseases 0.000 abstract description 6
208000024893 Acute lymphoblastic leukemia Diseases 0.000 abstract description 4
208000014697 Acute lymphocytic leukaemia Diseases 0.000 abstract description 4
208000031261 Acute myeloid leukaemia Diseases 0.000 abstract description 3
208000010833 Chronic myeloid leukaemia Diseases 0.000 abstract description 3
206010061218 Inflammation Diseases 0.000 abstract description 3
201000003793 Myelodysplastic syndrome Diseases 0.000 abstract description 3
208000014767 Myeloproliferative disease Diseases 0.000 abstract description 3
208000015914 Non-Hodgkin lymphomas Diseases 0.000 abstract description 3
230000004054 inflammatory process Effects 0.000 abstract description 3
206010027654 Allergic conditions Diseases 0.000 abstract description 2
208000003950 B-cell lymphoma Diseases 0.000 abstract description 2
208000032839 leukemia Diseases 0.000 abstract description 2
208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 abstract 2
208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 abstract 2
208000009052 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 abstract 1
208000017414 Precursor T-cell acute lymphoblastic leukemia Diseases 0.000 abstract 1
208000025747 Rheumatic disease Diseases 0.000 abstract 1
208000029052 T-cell acute lymphoblastic leukemia Diseases 0.000 abstract 1
206010003246 arthritis Diseases 0.000 abstract 1
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 83
238000000132 electrospray ionisation Methods 0.000 description 79
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 77
239000007787 solid Substances 0.000 description 77
238000006243 chemical reaction Methods 0.000 description 76
238000001819 mass spectrum Methods 0.000 description 71
230000015572 biosynthetic process Effects 0.000 description 67
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 66
238000003786 synthesis reaction Methods 0.000 description 63
210000004027 cell Anatomy 0.000 description 62
238000005481 NMR spectroscopy Methods 0.000 description 59
239000000243 solution Substances 0.000 description 58
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 55
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 54
239000012267 brine Substances 0.000 description 41
235000019439 ethyl acetate Nutrition 0.000 description 41
HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 41
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 38
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 35
206010012812 Diffuse cutaneous mastocytosis Diseases 0.000 description 34
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 33
239000012044 organic layer Substances 0.000 description 33
238000005160 1H NMR spectroscopy Methods 0.000 description 31
AUCXFLULRQIGPB-JTQLQIEISA-N 2-[(1s)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-n-ethyl-6-fluoroquinoline-3-carboxamide Chemical compound N([C@@H](C)C1=NC2=CC=C(F)C=C2C=C1C(=O)NCC)C1=NC=NC(N)=C1C#N AUCXFLULRQIGPB-JTQLQIEISA-N 0.000 description 31
238000004895 liquid chromatography mass spectrometry Methods 0.000 description 26
239000010410 layer Substances 0.000 description 25
108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 description 24
102000003993 Phosphatidylinositol 3-kinases Human genes 0.000 description 24
108010029485 Protein Isoforms Proteins 0.000 description 24
102000001708 Protein Isoforms Human genes 0.000 description 24
238000000746 purification Methods 0.000 description 24
241000699670 Mus sp. Species 0.000 description 23
IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 22
239000000047 product Substances 0.000 description 21
150000001732 carboxylic acid derivatives Chemical class 0.000 description 20
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 19
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 19
239000002904 solvent Substances 0.000 description 19
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 17
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 16
239000011734 sodium Substances 0.000 description 16
WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Substances C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 16
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 15
230000004913 activation Effects 0.000 description 15
210000004369 blood Anatomy 0.000 description 15
239000008280 blood Substances 0.000 description 15
239000000872 buffer Substances 0.000 description 15
238000004440 column chromatography Methods 0.000 description 15
239000003814 drug Substances 0.000 description 15
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 15
102100033810 RAC-alpha serine/threonine-protein kinase Human genes 0.000 description 14
DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 14
150000002148 esters Chemical class 0.000 description 14
239000000651 prodrug Substances 0.000 description 14
229940002612 prodrug Drugs 0.000 description 14
108090000623 proteins and genes Proteins 0.000 description 13
JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 12
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
239000002253 acid Substances 0.000 description 12
150000001412 amines Chemical class 0.000 description 12
150000001721 carbon Chemical group 0.000 description 12
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 11
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 11
230000014509 gene expression Effects 0.000 description 11
238000007429 general method Methods 0.000 description 11
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 11
239000000725 suspension Substances 0.000 description 11
KFPQTQWKIBDASB-QMMMGPOBSA-N 2-[(1s)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-5-fluoroquinoline-3-carboxylic acid Chemical compound N([C@@H](C)C=1C(=CC2=C(F)C=CC=C2N=1)C(O)=O)C1=NC=NC(N)=C1C#N KFPQTQWKIBDASB-QMMMGPOBSA-N 0.000 description 10
102000004190 Enzymes Human genes 0.000 description 10
108090000790 Enzymes Proteins 0.000 description 10
108091008611 Protein Kinase B Proteins 0.000 description 10
229940079593 drug Drugs 0.000 description 10
229940088598 enzyme Drugs 0.000 description 10
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 10
239000012074 organic phase Substances 0.000 description 10
238000002360 preparation method Methods 0.000 description 10
239000011541 reaction mixture Substances 0.000 description 10
230000002829 reductive effect Effects 0.000 description 10
230000011664 signaling Effects 0.000 description 10
238000003756 stirring Methods 0.000 description 10
CZTXUSDHYFIYOH-QMMMGPOBSA-N 2-[(1s)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-6-fluoroquinoline-3-carboxylic acid Chemical compound N([C@@H](C)C=1C(=CC2=CC(F)=CC=C2N=1)C(O)=O)C1=NC=NC(N)=C1C#N CZTXUSDHYFIYOH-QMMMGPOBSA-N 0.000 description 9
MPOSYZHWFLSOLP-LBPRGKRZSA-N 4-amino-6-[[(1s)-1-[8-fluoro-3-(pyrrolidine-1-carbonyl)quinolin-2-yl]ethyl]amino]pyrimidine-5-carbonitrile Chemical compound N([C@@H](C)C=1C(=CC2=CC=CC(F)=C2N=1)C(=O)N1CCCC1)C1=NC=NC(N)=C1C#N MPOSYZHWFLSOLP-LBPRGKRZSA-N 0.000 description 9
MAVMFCKRFRCMLE-UHFFFAOYSA-N 4-amino-6-chloropyrimidine-5-carbonitrile Chemical compound NC1=NC=NC(Cl)=C1C#N MAVMFCKRFRCMLE-UHFFFAOYSA-N 0.000 description 9
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
108010044467 Isoenzymes Proteins 0.000 description 9
238000003556 assay Methods 0.000 description 9
230000006870 function Effects 0.000 description 9
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 9
IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 9
239000003921 oil Substances 0.000 description 9
235000019198 oils Nutrition 0.000 description 9
125000006239 protecting group Chemical group 0.000 description 9
XVIAPHVAGFEFFN-UHFFFAOYSA-N pyrimidine-5-carbonitrile Chemical compound N#CC1=CN=CN=C1 XVIAPHVAGFEFFN-UHFFFAOYSA-N 0.000 description 9
YNCQUYDLASBIKU-QMMMGPOBSA-N 2-[(1s)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-8-chloroquinoline-3-carboxylic acid Chemical compound N([C@@H](C)C=1C(=CC2=CC=CC(Cl)=C2N=1)C(O)=O)C1=NC=NC(N)=C1C#N YNCQUYDLASBIKU-QMMMGPOBSA-N 0.000 description 8
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
108091000080 Phosphotransferase Proteins 0.000 description 8
239000000463 material Substances 0.000 description 8
230000035772 mutation Effects 0.000 description 8
102000020233 phosphotransferase Human genes 0.000 description 8
102000004169 proteins and genes Human genes 0.000 description 8
230000001105 regulatory effect Effects 0.000 description 8
210000001519 tissue Anatomy 0.000 description 8
241000699666 Mus <mouse, genus> Species 0.000 description 7
MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 7
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 7
WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 7
230000003197 catalytic effect Effects 0.000 description 7
201000010099 disease Diseases 0.000 description 7
UXXDARYIURDZSU-QMMMGPOBSA-N ethyl (4s)-4-[(2-methylpropan-2-yl)oxycarbonylamino]-3-oxopentanoate Chemical compound CCOC(=O)CC(=O)[C@H](C)NC(=O)OC(C)(C)C UXXDARYIURDZSU-QMMMGPOBSA-N 0.000 description 7
XCVCAJFIMRRBQW-NSHDSACASA-N ethyl 8-fluoro-2-[(1s)-1-[(2-methylpropan-2-yl)oxycarbonylamino]ethyl]quinoline-3-carboxylate Chemical compound C1=CC(F)=C2N=C([C@H](C)NC(=O)OC(C)(C)C)C(C(=O)OCC)=CC2=C1 XCVCAJFIMRRBQW-NSHDSACASA-N 0.000 description 7
125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 7
239000002609 medium Substances 0.000 description 7
NKGCZYKGVDLPNK-QMMMGPOBSA-N 2-[(1s)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-8-fluoroquinoline-3-carboxylic acid Chemical compound N([C@@H](C)C=1C(=CC2=CC=CC(F)=C2N=1)C(O)=O)C1=NC=NC(N)=C1C#N NKGCZYKGVDLPNK-QMMMGPOBSA-N 0.000 description 6
LPTRYUGKEUFNMQ-VIFPVBQESA-N 8-fluoro-2-[(1s)-1-[(2-methylpropan-2-yl)oxycarbonylamino]ethyl]quinoline-3-carboxylic acid Chemical compound C1=CC=C2C=C(C(O)=O)C([C@@H](NC(=O)OC(C)(C)C)C)=NC2=C1F LPTRYUGKEUFNMQ-VIFPVBQESA-N 0.000 description 6
241000283707 Capra Species 0.000 description 6
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 6
LFTLOKWAGJYHHR-UHFFFAOYSA-N N-methylmorpholine N-oxide Chemical compound CN1(=O)CCOCC1 LFTLOKWAGJYHHR-UHFFFAOYSA-N 0.000 description 6
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 6
229940024606 amino acid Drugs 0.000 description 6
239000012043 crude product Substances 0.000 description 6
UFDDSLYGYPEXPQ-UHFFFAOYSA-N methyl 2-[1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-6-fluoro-3-methoxyquinoline-4-carboxylate Chemical compound N=1C2=CC=C(F)C=C2C(C(=O)OC)=C(OC)C=1C(C)NC1=NC=NC(N)=C1C#N UFDDSLYGYPEXPQ-UHFFFAOYSA-N 0.000 description 6
150000003905 phosphatidylinositols Chemical class 0.000 description 6
238000010992 reflux Methods 0.000 description 6
238000000926 separation method Methods 0.000 description 6
238000010898 silica gel chromatography Methods 0.000 description 6
239000011780 sodium chloride Substances 0.000 description 6
JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 6
238000010186 staining Methods 0.000 description 6
230000000638 stimulation Effects 0.000 description 6
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 6
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
238000002965 ELISA Methods 0.000 description 5
CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 5
102000004877 Insulin Human genes 0.000 description 5
108090001061 Insulin Proteins 0.000 description 5
108010002350 Interleukin-2 Proteins 0.000 description 5
102000000588 Interleukin-2 Human genes 0.000 description 5
108090000315 Protein Kinase C Proteins 0.000 description 5
102000003923 Protein Kinase C Human genes 0.000 description 5
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
235000011054 acetic acid Nutrition 0.000 description 5
239000004480 active ingredient Substances 0.000 description 5
239000002671 adjuvant Substances 0.000 description 5
150000001413 amino acids Chemical class 0.000 description 5
239000000427 antigen Substances 0.000 description 5
102000036639 antigens Human genes 0.000 description 5
108091007433 antigens Proteins 0.000 description 5
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 5
238000004587 chromatography analysis Methods 0.000 description 5
235000019441 ethanol Nutrition 0.000 description 5
239000000706 filtrate Substances 0.000 description 5
125000004435 hydrogen atom Chemical group [H]* 0.000 description 5
230000007062 hydrolysis Effects 0.000 description 5
238000006460 hydrolysis reaction Methods 0.000 description 5
125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
238000001727 in vivo Methods 0.000 description 5
229940125396 insulin Drugs 0.000 description 5
239000007788 liquid Substances 0.000 description 5
210000001616 monocyte Anatomy 0.000 description 5
125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 5
210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 5
238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 5
238000012552 review Methods 0.000 description 5
239000007858 starting material Substances 0.000 description 5
239000000758 substrate Substances 0.000 description 5
239000006228 supernatant Substances 0.000 description 5
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 5
QDLHCMPXEPAAMD-QAIWCSMKSA-N wortmannin Chemical compound C1([C@]2(C)C3=C(C4=O)OC=C3C(=O)O[C@@H]2COC)=C4[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O QDLHCMPXEPAAMD-QAIWCSMKSA-N 0.000 description 5
QDLHCMPXEPAAMD-UHFFFAOYSA-N wortmannin Natural products COCC1OC(=O)C2=COC(C3=O)=C2C1(C)C1=C3C2CCC(=O)C2(C)CC1OC(C)=O QDLHCMPXEPAAMD-UHFFFAOYSA-N 0.000 description 5
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 description 4
BOQONZLZSVXVMI-UHFFFAOYSA-N 2-(aminomethyl)-n,n-diethyl-5-fluoroquinoline-3-carboxamide Chemical compound C1=CC=C2N=C(CN)C(C(=O)N(CC)CC)=CC2=C1F BOQONZLZSVXVMI-UHFFFAOYSA-N 0.000 description 4
SGCVNTNJULWFDC-UHFFFAOYSA-N 2-amino-5-fluorobenzaldehyde Chemical compound NC1=CC=C(F)C=C1C=O SGCVNTNJULWFDC-UHFFFAOYSA-N 0.000 description 4
QUYFSHOLLKVPGX-UHFFFAOYSA-N 3-methylsulfonylpropan-1-amine Chemical compound CS(=O)(=O)CCCN QUYFSHOLLKVPGX-UHFFFAOYSA-N 0.000 description 4
YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 4
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 4
DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 4
238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 4
108090000852 Forkhead Transcription Factors Proteins 0.000 description 4
102000004315 Forkhead Transcription Factors Human genes 0.000 description 4
OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 4
HGINADPHJQTSKN-UHFFFAOYSA-N Monoethyl malonic acid Chemical compound CCOC(=O)CC(O)=O HGINADPHJQTSKN-UHFFFAOYSA-N 0.000 description 4
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 4
DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 4
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 4
YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Chemical compound CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 description 4
230000002378 acidificating effect Effects 0.000 description 4
238000007605 air drying Methods 0.000 description 4
125000003277 amino group Chemical group 0.000 description 4
239000012131 assay buffer Substances 0.000 description 4
239000002585 base Substances 0.000 description 4
230000000903 blocking effect Effects 0.000 description 4
230000004663 cell proliferation Effects 0.000 description 4
230000005754 cellular signaling Effects 0.000 description 4
239000003153 chemical reaction reagent Substances 0.000 description 4
239000003795 chemical substances by application Substances 0.000 description 4
239000000460 chlorine Substances 0.000 description 4
235000015165 citric acid Nutrition 0.000 description 4
238000001816 cooling Methods 0.000 description 4
238000013461 design Methods 0.000 description 4
238000011161 development Methods 0.000 description 4
230000018109 developmental process Effects 0.000 description 4
150000002081 enamines Chemical class 0.000 description 4
238000005516 engineering process Methods 0.000 description 4
238000001914 filtration Methods 0.000 description 4
238000009472 formulation Methods 0.000 description 4
IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine hydrate Chemical compound O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 4
NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Chemical group O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 4
230000003053 immunization Effects 0.000 description 4
238000002649 immunization Methods 0.000 description 4
230000005764 inhibitory process Effects 0.000 description 4
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
238000013508 migration Methods 0.000 description 4
150000007522 mineralic acids Chemical class 0.000 description 4
SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 4
150000007524 organic acids Chemical class 0.000 description 4
229910000489 osmium tetroxide Inorganic materials 0.000 description 4
239000012285 osmium tetroxide Substances 0.000 description 4
150000003916 phosphatidylinositol 3,4,5-trisphosphates Chemical class 0.000 description 4
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
239000000843 powder Substances 0.000 description 4
125000004159 quinolin-2-yl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C([H])C(*)=NC2=C1[H] 0.000 description 4
238000006467 substitution reaction Methods 0.000 description 4
239000003826 tablet Substances 0.000 description 4
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 4
238000012360 testing method Methods 0.000 description 4
KPZSTOVTJYRDIO-UHFFFAOYSA-K trichlorocerium;heptahydrate Chemical compound O.O.O.O.O.O.O.Cl[Ce](Cl)Cl KPZSTOVTJYRDIO-UHFFFAOYSA-K 0.000 description 4
SZPQTEWIRPXBTC-KFOWTEFUSA-N 1,2-dipalmitoyl-sn-glycero-3-phospho-(1'D-myo-inositol-3'-phosphate) Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCC)COP(O)(=O)O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OP(O)(O)=O)[C@H]1O SZPQTEWIRPXBTC-KFOWTEFUSA-N 0.000 description 3
JHOIRIRNFPUMOP-UHFFFAOYSA-N 1-(5-fluoro-2-methylquinolin-3-yl)ethanone Chemical compound C1=CC=C2N=C(C)C(C(=O)C)=CC2=C1F JHOIRIRNFPUMOP-UHFFFAOYSA-N 0.000 description 3
ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical group C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 3
GNAFXKHKZDRBQS-UHFFFAOYSA-N 2-[(3-bromo-5-fluoroquinolin-2-yl)methyl]isoindole-1,3-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1CC1=C(Br)C=C2C(F)=CC=CC2=N1 GNAFXKHKZDRBQS-UHFFFAOYSA-N 0.000 description 3
KIFSSYJLDUQHDI-UHFFFAOYSA-N 2-[1-(3-bromo-6-fluoro-4-methoxyquinolin-2-yl)ethyl]isoindole-1,3-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1C(C)C1=NC2=CC=C(F)C=C2C(OC)=C1Br KIFSSYJLDUQHDI-UHFFFAOYSA-N 0.000 description 3
NKGCZYKGVDLPNK-UHFFFAOYSA-N 2-[1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-8-fluoroquinoline-3-carboxylic acid Chemical compound N=1C2=C(F)C=CC=C2C=C(C(O)=O)C=1C(C)NC1=NC=NC(N)=C1C#N NKGCZYKGVDLPNK-UHFFFAOYSA-N 0.000 description 3
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 3
MQAUKUSHPIYMTG-UHFFFAOYSA-N 2-[[3-[[ethyl(methyl)amino]methyl]-5-fluoroquinolin-2-yl]methyl]isoindole-1,3-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1CC1=NC2=CC=CC(F)=C2C=C1CN(C)CC MQAUKUSHPIYMTG-UHFFFAOYSA-N 0.000 description 3
PZBQRNQMWORUND-UHFFFAOYSA-N 2-amino-3-fluorobenzaldehyde Chemical compound NC1=C(F)C=CC=C1C=O PZBQRNQMWORUND-UHFFFAOYSA-N 0.000 description 3
DRYBIYUFOUZEOK-UHFFFAOYSA-N 2-amino-6-fluorobenzaldehyde Chemical compound NC1=CC=CC(F)=C1C=O DRYBIYUFOUZEOK-UHFFFAOYSA-N 0.000 description 3
CCMBVCUMLDKVBH-UHFFFAOYSA-N 3-bromo-2-(bromomethyl)-5-fluoroquinoline Chemical compound BrCC1=C(Br)C=C2C(F)=CC=CC2=N1 CCMBVCUMLDKVBH-UHFFFAOYSA-N 0.000 description 3
LGQOGLGFGMBYEU-UHFFFAOYSA-N 3-bromo-5-fluoro-2-methylquinoline Chemical compound C1=CC(F)=C2C=C(Br)C(C)=NC2=C1 LGQOGLGFGMBYEU-UHFFFAOYSA-N 0.000 description 3
FANPSEVRSPATGG-UHFFFAOYSA-N 5-fluoro-2-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]quinoline-3-carboxylic acid Chemical compound C1=CC(F)=C2C=C(C(O)=O)C(CNC(=O)OC(C)(C)C)=NC2=C1 FANPSEVRSPATGG-UHFFFAOYSA-N 0.000 description 3
XTCFFXJAEWCEGU-UHFFFAOYSA-N 5-fluoro-2-methylquinolin-3-amine Chemical compound C1=CC(F)=C2C=C(N)C(C)=NC2=C1 XTCFFXJAEWCEGU-UHFFFAOYSA-N 0.000 description 3
239000005711 Benzoic acid Substances 0.000 description 3
HTJDQJBWANPRPF-UHFFFAOYSA-N Cyclopropylamine Chemical compound NC1CC1 HTJDQJBWANPRPF-UHFFFAOYSA-N 0.000 description 3
102100025137 Early activation antigen CD69 Human genes 0.000 description 3
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
101000934374 Homo sapiens Early activation antigen CD69 Proteins 0.000 description 3
101000779418 Homo sapiens RAC-alpha serine/threonine-protein kinase Proteins 0.000 description 3
101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 3
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
108090000978 Interleukin-4 Proteins 0.000 description 3
CZQHHVNHHHRRDU-UHFFFAOYSA-N LY294002 Chemical compound C1=CC=C2C(=O)C=C(N3CCOCC3)OC2=C1C1=CC=CC=C1 CZQHHVNHHHRRDU-UHFFFAOYSA-N 0.000 description 3
241000124008 Mammalia Species 0.000 description 3
AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 3
102000038030 PI3Ks Human genes 0.000 description 3
UBXIJOJXUFYNRG-RJKBCLGNSA-N PIP[3'](17:0/20:4(5Z,8Z,11Z,14Z)) Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCC)COP(O)(=O)O[C@H]1C(O)C(O)C(O)[C@@H](OP(O)(O)=O)C1O UBXIJOJXUFYNRG-RJKBCLGNSA-N 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
229940124639 Selective inhibitor Drugs 0.000 description 3
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 3
241000282898 Sus scrofa Species 0.000 description 3
102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 3
HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 3
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
150000007513 acids Chemical class 0.000 description 3
230000009471 action Effects 0.000 description 3
125000002252 acyl group Chemical group 0.000 description 3
125000005042 acyloxymethyl group Chemical group 0.000 description 3
125000003118 aryl group Chemical group 0.000 description 3
230000008901 benefit Effects 0.000 description 3
235000010233 benzoic acid Nutrition 0.000 description 3
210000001185 bone marrow Anatomy 0.000 description 3
201000011510 cancer Diseases 0.000 description 3
239000002775 capsule Substances 0.000 description 3
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
229910052801 chlorine Inorganic materials 0.000 description 3
238000010367 cloning Methods 0.000 description 3
230000001086 cytosolic effect Effects 0.000 description 3
HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 3
IEHPAHJORKTHGT-UHFFFAOYSA-N ethyl 5-fluoro-2-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]quinoline-3-carboxylate Chemical compound C1=CC=C2N=C(CNC(=O)OC(C)(C)C)C(C(=O)OCC)=CC2=C1F IEHPAHJORKTHGT-UHFFFAOYSA-N 0.000 description 3
238000001943 fluorescence-activated cell sorting Methods 0.000 description 3
229910052731 fluorine Inorganic materials 0.000 description 3
230000012010 growth Effects 0.000 description 3
238000004128 high performance liquid chromatography Methods 0.000 description 3
238000007327 hydrogenolysis reaction Methods 0.000 description 3
PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 3
RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 3
230000003993 interaction Effects 0.000 description 3
238000011813 knockout mouse model Methods 0.000 description 3
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 3
239000011159 matrix material Substances 0.000 description 3
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 3
230000005012 migration Effects 0.000 description 3
238000010172 mouse model Methods 0.000 description 3
NJSDJPBREBLFCS-UHFFFAOYSA-N n-[[2-(aminomethyl)-5-fluoroquinolin-3-yl]methyl]-n-methylethanamine Chemical compound C1=CC=C2N=C(CN)C(CN(C)CC)=CC2=C1F NJSDJPBREBLFCS-UHFFFAOYSA-N 0.000 description 3
210000000440 neutrophil Anatomy 0.000 description 3
230000003287 optical effect Effects 0.000 description 3
235000005985 organic acids Nutrition 0.000 description 3
XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 3
OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 3
239000006187 pill Substances 0.000 description 3
229920000642 polymer Polymers 0.000 description 3
238000004007 reversed phase HPLC Methods 0.000 description 3
230000002441 reversible effect Effects 0.000 description 3
238000006884 silylation reaction Methods 0.000 description 3
239000002002 slurry Substances 0.000 description 3
229910052708 sodium Inorganic materials 0.000 description 3
229910052938 sodium sulfate Inorganic materials 0.000 description 3
235000011152 sodium sulphate Nutrition 0.000 description 3
238000001228 spectrum Methods 0.000 description 3
210000000952 spleen Anatomy 0.000 description 3
MUUVWRPUZNWWGL-UHFFFAOYSA-N tert-butyl n-[[3-(diethylcarbamoyl)-5-fluoroquinolin-2-yl]methyl]carbamate Chemical compound C1=CC=C2N=C(CNC(=O)OC(C)(C)C)C(C(=O)N(CC)CC)=CC2=C1F MUUVWRPUZNWWGL-UHFFFAOYSA-N 0.000 description 3
229940104230 thymidine Drugs 0.000 description 3
QIWRFOJWQSSRJZ-UHFFFAOYSA-N tributyl(ethenyl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C=C QIWRFOJWQSSRJZ-UHFFFAOYSA-N 0.000 description 3
239000003981 vehicle Substances 0.000 description 3
239000000080 wetting agent Substances 0.000 description 3
PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
VERSVOWJFSHXSI-UHFFFAOYSA-N (1,3-dimethylpyrazol-4-yl)methanamine Chemical compound CC1=NN(C)C=C1CN VERSVOWJFSHXSI-UHFFFAOYSA-N 0.000 description 2
XIHOYQMBAUMKCY-UHFFFAOYSA-N (2-amino-3-chlorophenyl)methanol Chemical compound NC1=C(Cl)C=CC=C1CO XIHOYQMBAUMKCY-UHFFFAOYSA-N 0.000 description 2
PHBLZACTWWFAER-UHFFFAOYSA-N (2-amino-6-fluorophenyl)methanol Chemical compound NC1=CC=CC(F)=C1CO PHBLZACTWWFAER-UHFFFAOYSA-N 0.000 description 2
QVHJQCGUWFKTSE-YFKPBYRVSA-N (2s)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound OC(=O)[C@H](C)NC(=O)OC(C)(C)C QVHJQCGUWFKTSE-YFKPBYRVSA-N 0.000 description 2
ZZHFPENWFNYNCE-OVCLIPMQSA-N (ne)-n-[1-(5-fluoro-2-methylquinolin-3-yl)ethylidene]hydroxylamine Chemical compound C1=CC=C2N=C(C)C(C(=N/O)/C)=CC2=C1F ZZHFPENWFNYNCE-OVCLIPMQSA-N 0.000 description 2
WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
HJFXLXRPJGBYQE-UHFFFAOYSA-N 1-(3-cyclopropyl-6-fluoro-4-methoxyquinolin-2-yl)ethanamine Chemical compound CC(N)C1=NC2=CC=C(F)C=C2C(OC)=C1C1CC1 HJFXLXRPJGBYQE-UHFFFAOYSA-N 0.000 description 2
VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
PAQZWJGSJMLPMG-UHFFFAOYSA-N 2,4,6-tripropyl-1,3,5,2$l^{5},4$l^{5},6$l^{5}-trioxatriphosphinane 2,4,6-trioxide Chemical compound CCCP1(=O)OP(=O)(CCC)OP(=O)(CCC)O1 PAQZWJGSJMLPMG-UHFFFAOYSA-N 0.000 description 2
MRYFBDRGEVRJLZ-UHFFFAOYSA-N 2-[(1,3-dioxoisoindol-2-yl)methyl]-5-fluoroquinoline-3-carbaldehyde Chemical compound O=C1C2=CC=CC=C2C(=O)N1CC1=C(C=O)C=C2C(F)=CC=CC2=N1 MRYFBDRGEVRJLZ-UHFFFAOYSA-N 0.000 description 2
JYVKSPITZUFPSE-NSHDSACASA-N 2-[(1s)-1-(1,3-dioxoisoindol-2-yl)ethyl]-6-fluoro-4-methoxyquinoline-3-carbaldehyde Chemical compound O=C1C2=CC=CC=C2C(=O)N1[C@@H](C)C1=NC2=CC=C(F)C=C2C(OC)=C1C=O JYVKSPITZUFPSE-NSHDSACASA-N 0.000 description 2
BGTLUCCMZGHTOF-LBPRGKRZSA-N 2-[(1s)-1-(3-ethenyl-6-fluoro-4-methoxyquinolin-2-yl)ethyl]isoindole-1,3-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1[C@@H](C)C1=NC2=CC=C(F)C=C2C(OC)=C1C=C BGTLUCCMZGHTOF-LBPRGKRZSA-N 0.000 description 2
AKGBQQKJKVSRMC-ZDUSSCGKSA-N 2-[(1s)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-n-[(2,5-dimethylpyrazol-3-yl)methyl]-5-fluoroquinoline-3-carboxamide Chemical compound N([C@@H](C)C=1C(=CC2=C(F)C=CC=C2N=1)C(=O)NCC=1N(N=C(C)C=1)C)C1=NC=NC(N)=C1C#N AKGBQQKJKVSRMC-ZDUSSCGKSA-N 0.000 description 2
LNXXBFNMTKUWGB-UHFFFAOYSA-N 2-[(3-ethenyl-5-fluoroquinolin-2-yl)methyl]isoindole-1,3-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1CC1=C(C=C)C=C2C(F)=CC=CC2=N1 LNXXBFNMTKUWGB-UHFFFAOYSA-N 0.000 description 2
YEQROQVWTCGCCI-UHFFFAOYSA-N 2-[1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-6-fluoro-3-methoxyquinoline-4-carboxylic acid Chemical compound N1=C2C=CC(F)=CC2=C(C(O)=O)C(OC)=C1C(C)NC1=NC=NC(N)=C1C#N YEQROQVWTCGCCI-UHFFFAOYSA-N 0.000 description 2
FVFGTMXRHNSEMC-UHFFFAOYSA-N 2-amino-3-chlorobenzaldehyde Chemical compound NC1=C(Cl)C=CC=C1C=O FVFGTMXRHNSEMC-UHFFFAOYSA-N 0.000 description 2
LWUAMROXVQLJKA-UHFFFAOYSA-N 2-amino-3-chlorobenzoic acid Chemical compound NC1=C(Cl)C=CC=C1C(O)=O LWUAMROXVQLJKA-UHFFFAOYSA-N 0.000 description 2
PSYUREKQBXGPTJ-UHFFFAOYSA-N 2-ethyl-6-fluoro-3-hydroxyquinoline-4-carboxylic acid Chemical compound C1=C(F)C=C2C(C(O)=O)=C(O)C(CC)=NC2=C1 PSYUREKQBXGPTJ-UHFFFAOYSA-N 0.000 description 2
NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 description 2
SDNXQWUJWNTDCC-UHFFFAOYSA-N 2-methylsulfonylethanamine Chemical compound CS(=O)(=O)CCN SDNXQWUJWNTDCC-UHFFFAOYSA-N 0.000 description 2
125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 2
ASTDKNJEDKQYQQ-UHFFFAOYSA-N 4-amino-6-[1-(3-cyclopropyl-6-fluoro-4-methoxyquinolin-2-yl)ethylamino]pyrimidine-5-carbonitrile Chemical compound N=1C=NC(N)=C(C#N)C=1NC(C)C1=NC2=CC=C(F)C=C2C(OC)=C1C1CC1 ASTDKNJEDKQYQQ-UHFFFAOYSA-N 0.000 description 2
QIEBKDLXKZAIMZ-UHFFFAOYSA-N 4-amino-6-[1-[6-fluoro-4-(3-hydroxyazetidine-1-carbonyl)-3-methoxyquinolin-2-yl]ethylamino]pyrimidine-5-carbonitrile Chemical compound COC1=C(C(C)NC=2C(=C(N)N=CN=2)C#N)N=C2C=CC(F)=CC2=C1C(=O)N1CC(O)C1 QIEBKDLXKZAIMZ-UHFFFAOYSA-N 0.000 description 2
FCDOPWPLXFENHF-UHFFFAOYSA-N 4-amino-6-[1-[6-fluoro-4-oxo-3-(piperazin-1-ylmethyl)-1h-quinolin-2-yl]ethylamino]pyrimidine-5-carbonitrile Chemical compound N=1C2=CC=C(F)C=C2C(O)=C(CN2CCNCC2)C=1C(C)NC1=NC=NC(N)=C1C#N FCDOPWPLXFENHF-UHFFFAOYSA-N 0.000 description 2
ASTDKNJEDKQYQQ-JTQLQIEISA-N 4-amino-6-[[(1s)-1-(3-cyclopropyl-6-fluoro-4-methoxyquinolin-2-yl)ethyl]amino]pyrimidine-5-carbonitrile Chemical compound C1([C@H](C)NC=2C(=C(N)N=CN=2)C#N)=NC2=CC=C(F)C=C2C(OC)=C1C1CC1 ASTDKNJEDKQYQQ-JTQLQIEISA-N 0.000 description 2
VYCSHEGLUOOAHR-UHFFFAOYSA-N 4-amino-6-[[3-[[ethyl(methyl)amino]methyl]-5-fluoroquinolin-2-yl]methylamino]pyrimidine-5-carbonitrile Chemical compound CCN(C)CC1=CC2=C(F)C=CC=C2N=C1CNC1=NC=NC(N)=C1C#N VYCSHEGLUOOAHR-UHFFFAOYSA-N 0.000 description 2
ZSOJUWQBWBFXQB-VIFPVBQESA-N 5-fluoro-2-[(1s)-1-[(2-methylpropan-2-yl)oxycarbonylamino]ethyl]quinoline-3-carboxylic acid Chemical compound C1=CC(F)=C2C=C(C(O)=O)C([C@@H](NC(=O)OC(C)(C)C)C)=NC2=C1 ZSOJUWQBWBFXQB-VIFPVBQESA-N 0.000 description 2
IYPPSTWIXLXNOA-VIFPVBQESA-N 6-fluoro-2-[(1s)-1-[(2-methylpropan-2-yl)oxycarbonylamino]ethyl]quinoline-3-carboxylic acid Chemical compound C1=C(F)C=C2C=C(C(O)=O)C([C@@H](NC(=O)OC(C)(C)C)C)=NC2=C1 IYPPSTWIXLXNOA-VIFPVBQESA-N 0.000 description 2
BKNJECAQRMFTCF-VIFPVBQESA-N 8-chloro-2-[(1s)-1-[(2-methylpropan-2-yl)oxycarbonylamino]ethyl]quinoline-3-carboxylic acid Chemical compound C1=CC=C2C=C(C(O)=O)C([C@@H](NC(=O)OC(C)(C)C)C)=NC2=C1Cl BKNJECAQRMFTCF-VIFPVBQESA-N 0.000 description 2
LPTRYUGKEUFNMQ-UHFFFAOYSA-N 8-fluoro-2-[1-[(2-methylpropan-2-yl)oxycarbonylamino]ethyl]quinoline-3-carboxylic acid Chemical compound C1=CC=C2C=C(C(O)=O)C(C(NC(=O)OC(C)(C)C)C)=NC2=C1F LPTRYUGKEUFNMQ-UHFFFAOYSA-N 0.000 description 2
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 2
239000004342 Benzoyl peroxide Substances 0.000 description 2
OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 2
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 2
108010029697 CD40 Ligand Proteins 0.000 description 2
102100032937 CD40 ligand Human genes 0.000 description 2
206010008342 Cervix carcinoma Diseases 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
108091007958 Class I PI3Ks Proteins 0.000 description 2
108020004705 Codon Proteins 0.000 description 2
229910021589 Copper(I) bromide Inorganic materials 0.000 description 2
108010006124 DNA-Activated Protein Kinase Proteins 0.000 description 2
102000005768 DNA-Activated Protein Kinase Human genes 0.000 description 2
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 2
108090000371 Esterases Proteins 0.000 description 2
229920001917 Ficoll Polymers 0.000 description 2
102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 2
108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 2
230000005526 G1 to G0 transition Effects 0.000 description 2
241000238631 Hexapoda Species 0.000 description 2
101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 2
101000873927 Homo sapiens Squamous cell carcinoma antigen recognized by T-cells 3 Proteins 0.000 description 2
AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 2
WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
102100037852 Insulin-like growth factor I Human genes 0.000 description 2
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
102000016267 Leptin Human genes 0.000 description 2
108010092277 Leptin Proteins 0.000 description 2
206010058467 Lung neoplasm malignant Diseases 0.000 description 2
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
101100030361 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pph-3 gene Proteins 0.000 description 2
241000283973 Oryctolagus cuniculus Species 0.000 description 2
206010033128 Ovarian cancer Diseases 0.000 description 2
206010061535 Ovarian neoplasm Diseases 0.000 description 2
WSLBJQQQZZTFBA-MLUQOLBVSA-N PIP[4'](17:0/20:4(5Z,8Z,11Z,14Z)) Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCC)COP(O)(=O)OC1C(O)C(O)C(OP(O)(O)=O)[C@@H](O)C1O WSLBJQQQZZTFBA-MLUQOLBVSA-N 0.000 description 2
NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
239000004698 Polyethylene Substances 0.000 description 2
OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
102000001253 Protein Kinase Human genes 0.000 description 2
102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 2
108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 2
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 2
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
229920002472 Starch Polymers 0.000 description 2
229930006000 Sucrose Natural products 0.000 description 2
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
230000006044 T cell activation Effects 0.000 description 2
239000007983 Tris buffer Substances 0.000 description 2
GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 2
208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 2
JEDZLBFUGJTJGQ-UHFFFAOYSA-N [Na].COCCO[AlH]OCCOC Chemical compound [Na].COCCO[AlH]OCCOC JEDZLBFUGJTJGQ-UHFFFAOYSA-N 0.000 description 2
150000001299 aldehydes Chemical class 0.000 description 2
125000003545 alkoxy group Chemical group 0.000 description 2
125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
229940037003 alum Drugs 0.000 description 2
229910000147 aluminium phosphate Inorganic materials 0.000 description 2
230000006907 apoptotic process Effects 0.000 description 2
238000013459 approach Methods 0.000 description 2
208000006673 asthma Diseases 0.000 description 2
125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 2
235000019400 benzoyl peroxide Nutrition 0.000 description 2
125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 2
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 2
230000037396 body weight Effects 0.000 description 2
229910052794 bromium Inorganic materials 0.000 description 2
150000001649 bromium compounds Chemical class 0.000 description 2
PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
239000000969 carrier Substances 0.000 description 2
230000003915 cell function Effects 0.000 description 2
210000000170 cell membrane Anatomy 0.000 description 2
201000010881 cervical cancer Diseases 0.000 description 2
229940099352 cholate Drugs 0.000 description 2
BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 2
NKNDPYCGAZPOFS-UHFFFAOYSA-M copper(i) bromide Chemical compound Br[Cu] NKNDPYCGAZPOFS-UHFFFAOYSA-M 0.000 description 2
238000002425 crystallisation Methods 0.000 description 2
230000008025 crystallization Effects 0.000 description 2
125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
VRLDVERQJMEPIF-UHFFFAOYSA-N dbdmh Chemical compound CC1(C)N(Br)C(=O)N(Br)C1=O VRLDVERQJMEPIF-UHFFFAOYSA-N 0.000 description 2
230000007547 defect Effects 0.000 description 2
239000002552 dosage form Substances 0.000 description 2
230000036267 drug metabolism Effects 0.000 description 2
239000000839 emulsion Substances 0.000 description 2
210000002889 endothelial cell Anatomy 0.000 description 2
CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 2
150000002170 ethers Chemical class 0.000 description 2
MFRFJFDLZKHOFX-UHFFFAOYSA-N ethyl 4-[(2-methylpropan-2-yl)oxycarbonylamino]-3-oxobutanoate Chemical compound CCOC(=O)CC(=O)CNC(=O)OC(C)(C)C MFRFJFDLZKHOFX-UHFFFAOYSA-N 0.000 description 2
UXXDARYIURDZSU-UHFFFAOYSA-N ethyl 4-[(2-methylpropan-2-yl)oxycarbonylamino]-3-oxopentanoate Chemical compound CCOC(=O)CC(=O)C(C)NC(=O)OC(C)(C)C UXXDARYIURDZSU-UHFFFAOYSA-N 0.000 description 2
XCVCAJFIMRRBQW-UHFFFAOYSA-N ethyl 8-fluoro-2-[1-[(2-methylpropan-2-yl)oxycarbonylamino]ethyl]quinoline-3-carboxylate Chemical compound C1=CC(F)=C2N=C(C(C)NC(=O)OC(C)(C)C)C(C(=O)OCC)=CC2=C1 XCVCAJFIMRRBQW-UHFFFAOYSA-N 0.000 description 2
238000001704 evaporation Methods 0.000 description 2
230000008020 evaporation Effects 0.000 description 2
230000007717 exclusion Effects 0.000 description 2
239000008187 granular material Substances 0.000 description 2
239000001963 growth medium Substances 0.000 description 2
150000004820 halides Chemical group 0.000 description 2
229910052736 halogen Inorganic materials 0.000 description 2
238000003306 harvesting Methods 0.000 description 2
210000003630 histaminocyte Anatomy 0.000 description 2
229940088597 hormone Drugs 0.000 description 2
239000005556 hormone Substances 0.000 description 2
150000003949 imides Chemical class 0.000 description 2
210000000987 immune system Anatomy 0.000 description 2
230000036039 immunity Effects 0.000 description 2
238000000338 in vitro Methods 0.000 description 2
239000003701 inert diluent Substances 0.000 description 2
238000002347 injection Methods 0.000 description 2
239000007924 injection Substances 0.000 description 2
CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical group O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
150000004694 iodide salts Chemical class 0.000 description 2
229910052740 iodine Inorganic materials 0.000 description 2
238000002955 isolation Methods 0.000 description 2
238000002372 labelling Methods 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
239000008101 lactose Substances 0.000 description 2
NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 2
229940039781 leptin Drugs 0.000 description 2
231100000518 lethal Toxicity 0.000 description 2
230000001665 lethal effect Effects 0.000 description 2
210000000265 leukocyte Anatomy 0.000 description 2
150000002632 lipids Chemical class 0.000 description 2
GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium;hydroxide;hydrate Chemical compound [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 description 2
210000004072 lung Anatomy 0.000 description 2
201000005202 lung cancer Diseases 0.000 description 2
208000020816 lung neoplasm Diseases 0.000 description 2
210000003563 lymphoid tissue Anatomy 0.000 description 2
235000019359 magnesium stearate Nutrition 0.000 description 2
239000011976 maleic acid Substances 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
238000004949 mass spectrometry Methods 0.000 description 2
230000004060 metabolic process Effects 0.000 description 2
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
IJTAWEHODSPJIB-UHFFFAOYSA-N methyl 2-(1-aminoethyl)-6-fluoro-3-methoxyquinoline-4-carboxylate Chemical compound C1=C(F)C=C2C(C(=O)OC)=C(OC)C(C(C)N)=NC2=C1 IJTAWEHODSPJIB-UHFFFAOYSA-N 0.000 description 2
MHGXCIOEUWCMBB-UHFFFAOYSA-N methyl 2-(1-azidoethyl)-6-fluoro-3-methoxyquinoline-4-carboxylate Chemical compound C1=C(F)C=C2C(C(=O)OC)=C(OC)C(C(C)N=[N+]=[N-])=NC2=C1 MHGXCIOEUWCMBB-UHFFFAOYSA-N 0.000 description 2
GESMRJZUHQXKAA-UHFFFAOYSA-N methyl 2-(1-bromoethyl)-6-fluoro-3-methoxyquinoline-4-carboxylate Chemical compound C1=C(F)C=C2C(C(=O)OC)=C(OC)C(C(C)Br)=NC2=C1 GESMRJZUHQXKAA-UHFFFAOYSA-N 0.000 description 2
LINUSAYYTXJWAC-UHFFFAOYSA-N methyl 2-ethyl-6-fluoro-3-methoxyquinoline-4-carboxylate Chemical compound C1=C(F)C=C2C(C(=O)OC)=C(OC)C(CC)=NC2=C1 LINUSAYYTXJWAC-UHFFFAOYSA-N 0.000 description 2
XFBRYANFYGGTGX-UHFFFAOYSA-N n-(5-fluoro-2-methylquinolin-3-yl)acetamide Chemical compound C1=CC=C2N=C(C)C(NC(=O)C)=CC2=C1F XFBRYANFYGGTGX-UHFFFAOYSA-N 0.000 description 2
DEYFEUNBLGUWTN-UHFFFAOYSA-N n-propan-2-ylquinoline-3-carboxamide Chemical compound C1=CC=CC2=CC(C(=O)NC(C)C)=CN=C21 DEYFEUNBLGUWTN-UHFFFAOYSA-N 0.000 description 2
210000004897 n-terminal region Anatomy 0.000 description 2
125000004433 nitrogen atom Chemical group N* 0.000 description 2
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
239000000346 nonvolatile oil Substances 0.000 description 2
239000012038 nucleophile Substances 0.000 description 2
235000006408 oxalic acid Nutrition 0.000 description 2
230000003647 oxidation Effects 0.000 description 2
238000007254 oxidation reaction Methods 0.000 description 2
150000002923 oximes Chemical class 0.000 description 2
NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
238000005192 partition Methods 0.000 description 2
239000012071 phase Substances 0.000 description 2
UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 2
150000003906 phosphoinositides Chemical class 0.000 description 2
229910052698 phosphorus Inorganic materials 0.000 description 2
RFIOZSIHFNEKFF-UHFFFAOYSA-M piperazine-1-carboxylate Chemical compound [O-]C(=O)N1CCNCC1 RFIOZSIHFNEKFF-UHFFFAOYSA-M 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
229910000027 potassium carbonate Inorganic materials 0.000 description 2
230000008569 process Effects 0.000 description 2
230000035755 proliferation Effects 0.000 description 2
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
108060006633 protein kinase Proteins 0.000 description 2
BLTDCIWCFCUQCB-UHFFFAOYSA-N quinoline-3-carboxamide Chemical compound C1=CC=CC2=CC(C(=O)N)=CN=C21 BLTDCIWCFCUQCB-UHFFFAOYSA-N 0.000 description 2
150000003254 radicals Chemical class 0.000 description 2
230000009467 reduction Effects 0.000 description 2
238000006722 reduction reaction Methods 0.000 description 2
238000011160 research Methods 0.000 description 2
230000004044 response Effects 0.000 description 2
YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
230000019491 signal transduction Effects 0.000 description 2
210000003491 skin Anatomy 0.000 description 2
150000003384 small molecules Chemical class 0.000 description 2
239000012419 sodium bis(2-methoxyethoxy)aluminum hydride Substances 0.000 description 2
LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
239000012321 sodium triacetoxyborohydride Substances 0.000 description 2
239000007909 solid dosage form Substances 0.000 description 2
238000000527 sonication Methods 0.000 description 2
239000008107 starch Substances 0.000 description 2
235000019698 starch Nutrition 0.000 description 2
239000000126 substance Substances 0.000 description 2
239000005720 sucrose Substances 0.000 description 2
238000004808 supercritical fluid chromatography Methods 0.000 description 2
239000000829 suppository Substances 0.000 description 2
230000004083 survival effect Effects 0.000 description 2
239000006188 syrup Substances 0.000 description 2
235000020357 syrup Nutrition 0.000 description 2
ADCPPDRVVHZQLO-INIZCTEOSA-N tert-butyl 4-[[2-[(1s)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-6-fluoro-4-methoxyquinolin-3-yl]methyl]piperazine-1-carboxylate Chemical compound C1([C@H](C)NC=2C(=C(N)N=CN=2)C#N)=NC2=CC=C(F)C=C2C(OC)=C1CN1CCN(C(=O)OC(C)(C)C)CC1 ADCPPDRVVHZQLO-INIZCTEOSA-N 0.000 description 2
BDTAQGOJLVFTRJ-UHFFFAOYSA-N tert-butyl n-[[3-(diethylaminomethyl)-5-fluoroquinolin-2-yl]methyl]carbamate Chemical compound C1=CC=C2N=C(CNC(=O)OC(C)(C)C)C(CN(CC)CC)=CC2=C1F BDTAQGOJLVFTRJ-UHFFFAOYSA-N 0.000 description 2
229960000814 tetanus toxoid Drugs 0.000 description 2
VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
229940124597 therapeutic agent Drugs 0.000 description 2
238000004809 thin layer chromatography Methods 0.000 description 2
125000003396 thiol group Chemical group [H]S* 0.000 description 2
238000011200 topical administration Methods 0.000 description 2
230000005945 translocation Effects 0.000 description 2
108010042685 trinitrophenyl keyhole limpet hemocyanin Proteins 0.000 description 2
108010055746 trinitrophenyl-bovine serum albumin Proteins 0.000 description 2
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
241000701447 unidentified baculovirus Species 0.000 description 2
210000000689 upper leg Anatomy 0.000 description 2
LSPHULWDVZXLIL-UHFFFAOYSA-N (+/-)-Camphoric acid Chemical compound CC1(C)C(C(O)=O)CCC1(C)C(O)=O LSPHULWDVZXLIL-UHFFFAOYSA-N 0.000 description 1
ZRAZJGBWNZUSGQ-UHFFFAOYSA-N (2-amino-5-fluorophenyl)methanol Chemical compound NC1=CC=C(F)C=C1CO ZRAZJGBWNZUSGQ-UHFFFAOYSA-N 0.000 description 1
QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
ZYSROTXGZVWOCT-UHFFFAOYSA-N (3-propan-2-yl-1,2-oxazol-4-yl)methanamine Chemical compound CC(C)C1=NOC=C1CN ZYSROTXGZVWOCT-UHFFFAOYSA-N 0.000 description 1
SQWZFLMPDUSYGV-POHAHGRESA-N (5Z)-5-(quinoxalin-6-ylmethylidene)-1,3-thiazolidine-2,4-dione Chemical compound S1C(=O)NC(=O)\C1=C\C1=CC=C(N=CC=N2)C2=C1 SQWZFLMPDUSYGV-POHAHGRESA-N 0.000 description 1
WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
KOFLVDBWRHFSAB-UHFFFAOYSA-N 1,2,4,5-tetrahydro-1-(phenylmethyl)-5,9b(1',2')-benzeno-9bh-benz(g)indol-3(3ah)-one Chemical compound C1C(C=2C3=CC=CC=2)C2=CC=CC=C2C23C1C(=O)CN2CC1=CC=CC=C1 KOFLVDBWRHFSAB-UHFFFAOYSA-N 0.000 description 1
KPZGRMZPZLOPBS-UHFFFAOYSA-N 1,3-dichloro-2,2-bis(chloromethyl)propane Chemical compound ClCC(CCl)(CCl)CCl KPZGRMZPZLOPBS-UHFFFAOYSA-N 0.000 description 1
CCXQVBSQUQCEEO-UHFFFAOYSA-N 1-bromobutan-2-one Chemical compound CCC(=O)CBr CCXQVBSQUQCEEO-UHFFFAOYSA-N 0.000 description 1
VFWCMGCRMGJXDK-UHFFFAOYSA-N 1-chlorobutane Chemical compound CCCCCl VFWCMGCRMGJXDK-UHFFFAOYSA-N 0.000 description 1
VUQPJRPDRDVQMN-UHFFFAOYSA-N 1-chlorooctadecane Chemical class CCCCCCCCCCCCCCCCCCCl VUQPJRPDRDVQMN-UHFFFAOYSA-N 0.000 description 1
IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
UTQNKKSJPHTPBS-UHFFFAOYSA-N 2,2,2-trichloroethanone Chemical group ClC(Cl)(Cl)[C]=O UTQNKKSJPHTPBS-UHFFFAOYSA-N 0.000 description 1
VMJNTFXCTXAXTC-UHFFFAOYSA-N 2,2-difluoro-1,3-benzodioxole-5-carbonitrile Chemical group C1=C(C#N)C=C2OC(F)(F)OC2=C1 VMJNTFXCTXAXTC-UHFFFAOYSA-N 0.000 description 1
NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
GPWNWKWQOLEVEQ-UHFFFAOYSA-N 2,4-diaminopyrimidine-5-carbaldehyde Chemical compound NC1=NC=C(C=O)C(N)=N1 GPWNWKWQOLEVEQ-UHFFFAOYSA-N 0.000 description 1
LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
KAKVYXRPFPRQDF-LLVKDONJSA-N 2-[(1r)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-8-fluoro-n-propan-2-ylquinoline-3-carboxamide Chemical compound N([C@H](C)C1=NC2=C(F)C=CC=C2C=C1C(=O)NC(C)C)C1=NC=NC(N)=C1C#N KAKVYXRPFPRQDF-LLVKDONJSA-N 0.000 description 1
KIFSSYJLDUQHDI-JTQLQIEISA-N 2-[(1s)-1-(3-bromo-6-fluoro-4-methoxyquinolin-2-yl)ethyl]isoindole-1,3-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1[C@@H](C)C1=NC2=CC=C(F)C=C2C(OC)=C1Br KIFSSYJLDUQHDI-JTQLQIEISA-N 0.000 description 1
NOBQHQPWEUADFU-JTQLQIEISA-N 2-[(1s)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-5-fluoro-n-(2-hydroxyethyl)quinoline-3-carboxamide Chemical compound N([C@@H](C)C=1C(=CC2=C(F)C=CC=C2N=1)C(=O)NCCO)C1=NC=NC(N)=C1C#N NOBQHQPWEUADFU-JTQLQIEISA-N 0.000 description 1
FQYGYZZLJWTQOY-LBPRGKRZSA-N 2-[(1s)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-5-fluoro-n-(3-methylsulfonylpropyl)quinoline-3-carboxamide Chemical compound N([C@@H](C)C=1C(=CC2=C(F)C=CC=C2N=1)C(=O)NCCCS(C)(=O)=O)C1=NC=NC(N)=C1C#N FQYGYZZLJWTQOY-LBPRGKRZSA-N 0.000 description 1
GFDWQQXDAKRNJQ-ZDUSSCGKSA-N 2-[(1s)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-5-fluoro-n-(oxan-4-ylmethyl)quinoline-3-carboxamide Chemical compound N([C@@H](C)C=1C(=CC2=C(F)C=CC=C2N=1)C(=O)NCC1CCOCC1)C1=NC=NC(N)=C1C#N GFDWQQXDAKRNJQ-ZDUSSCGKSA-N 0.000 description 1
KLRBLRBXUZWPBY-ZDUSSCGKSA-N 2-[(1s)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-5-fluoro-n-(pyridin-2-ylmethyl)quinoline-3-carboxamide Chemical compound N([C@@H](C)C=1C(=CC2=C(F)C=CC=C2N=1)C(=O)NCC=1N=CC=CC=1)C1=NC=NC(N)=C1C#N KLRBLRBXUZWPBY-ZDUSSCGKSA-N 0.000 description 1
XYSAXGIDDNGKAZ-NSHDSACASA-N 2-[(1s)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-5-fluoro-n-propan-2-ylquinoline-3-carboxamide Chemical compound N([C@@H](C)C1=NC2=CC=CC(F)=C2C=C1C(=O)NC(C)C)C1=NC=NC(N)=C1C#N XYSAXGIDDNGKAZ-NSHDSACASA-N 0.000 description 1
AFLHMEQRTXBIHC-DTIOYNMSSA-N 2-[(1s)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-6-fluoro-n-(2-hydroxypropyl)quinoline-3-carboxamide Chemical compound N([C@@H](C)C1=NC2=CC=C(F)C=C2C=C1C(=O)NCC(O)C)C1=NC=NC(N)=C1C#N AFLHMEQRTXBIHC-DTIOYNMSSA-N 0.000 description 1
KIMNYYQRVRUDPG-NSHDSACASA-N 2-[(1s)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-6-fluoro-n-(2-methylsulfonylethyl)quinoline-3-carboxamide Chemical compound N([C@@H](C)C=1C(=CC2=CC(F)=CC=C2N=1)C(=O)NCCS(C)(=O)=O)C1=NC=NC(N)=C1C#N KIMNYYQRVRUDPG-NSHDSACASA-N 0.000 description 1
BNFIXTTXACWVAG-LBPRGKRZSA-N 2-[(1s)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-6-fluoro-n-(3-methylsulfonylpropyl)quinoline-3-carboxamide Chemical compound N([C@@H](C)C=1C(=CC2=CC(F)=CC=C2N=1)C(=O)NCCCS(C)(=O)=O)C1=NC=NC(N)=C1C#N BNFIXTTXACWVAG-LBPRGKRZSA-N 0.000 description 1
AGYTUPRAFDJMJX-ZDUSSCGKSA-N 2-[(1s)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-6-fluoro-n-(pyridin-2-ylmethyl)quinoline-3-carboxamide Chemical compound N([C@@H](C)C=1C(=CC2=CC(F)=CC=C2N=1)C(=O)NCC=1N=CC=CC=1)C1=NC=NC(N)=C1C#N AGYTUPRAFDJMJX-ZDUSSCGKSA-N 0.000 description 1
VGIUFQYHOWWADV-ZDUSSCGKSA-N 2-[(1s)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-6-fluoro-n-(pyridin-3-ylmethyl)quinoline-3-carboxamide Chemical compound N([C@@H](C)C=1C(=CC2=CC(F)=CC=C2N=1)C(=O)NCC=1C=NC=CC=1)C1=NC=NC(N)=C1C#N VGIUFQYHOWWADV-ZDUSSCGKSA-N 0.000 description 1
DTFOZOOYWJMHBR-VIFPVBQESA-N 2-[(1s)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-6-fluoro-n-methylquinoline-3-carboxamide Chemical compound N([C@@H](C)C1=NC2=CC=C(F)C=C2C=C1C(=O)NC)C1=NC=NC(N)=C1C#N DTFOZOOYWJMHBR-VIFPVBQESA-N 0.000 description 1
NZUIDGGBLHIYQB-JTQLQIEISA-N 2-[(1s)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-8-chloro-n-(2-hydroxyethyl)quinoline-3-carboxamide Chemical compound N([C@@H](C)C=1C(=CC2=CC=CC(Cl)=C2N=1)C(=O)NCCO)C1=NC=NC(N)=C1C#N NZUIDGGBLHIYQB-JTQLQIEISA-N 0.000 description 1
BBFJYWVLRMIJNM-LBPRGKRZSA-N 2-[(1s)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-8-chloro-n-(3-methylsulfonylpropyl)quinoline-3-carboxamide Chemical compound N([C@@H](C)C=1C(=CC2=CC=CC(Cl)=C2N=1)C(=O)NCCCS(C)(=O)=O)C1=NC=NC(N)=C1C#N BBFJYWVLRMIJNM-LBPRGKRZSA-N 0.000 description 1
GNBDGHHQVOGVSH-AWEZNQCLSA-N 2-[(1s)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-8-chloro-n-(4,4-dimethylcyclohexyl)quinoline-3-carboxamide Chemical compound N([C@@H](C)C=1C(=CC2=CC=CC(Cl)=C2N=1)C(=O)NC1CCC(C)(C)CC1)C1=NC=NC(N)=C1C#N GNBDGHHQVOGVSH-AWEZNQCLSA-N 0.000 description 1
ULPNRNQZVGPRNM-NSHDSACASA-N 2-[(1s)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-8-chloro-n-(cyclopropylmethyl)quinoline-3-carboxamide Chemical compound N([C@@H](C)C=1C(=CC2=CC=CC(Cl)=C2N=1)C(=O)NCC1CC1)C1=NC=NC(N)=C1C#N ULPNRNQZVGPRNM-NSHDSACASA-N 0.000 description 1
PWQDSXJKULJMPW-ZDUSSCGKSA-N 2-[(1s)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-8-chloro-n-(oxan-4-ylmethyl)quinoline-3-carboxamide Chemical compound N([C@@H](C)C=1C(=CC2=CC=CC(Cl)=C2N=1)C(=O)NCC1CCOCC1)C1=NC=NC(N)=C1C#N PWQDSXJKULJMPW-ZDUSSCGKSA-N 0.000 description 1
BAYPXKLFNISEKR-ZDUSSCGKSA-N 2-[(1s)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-8-chloro-n-(pyridin-2-ylmethyl)quinoline-3-carboxamide Chemical compound N([C@@H](C)C=1C(=CC2=CC=CC(Cl)=C2N=1)C(=O)NCC=1N=CC=CC=1)C1=NC=NC(N)=C1C#N BAYPXKLFNISEKR-ZDUSSCGKSA-N 0.000 description 1
MEVPWIPNARLDCN-ZDUSSCGKSA-N 2-[(1s)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-8-chloro-n-[(2,5-dimethylpyrazol-3-yl)methyl]quinoline-3-carboxamide Chemical compound N([C@@H](C)C=1C(=CC2=CC=CC(Cl)=C2N=1)C(=O)NCC=1N(N=C(C)C=1)C)C1=NC=NC(N)=C1C#N MEVPWIPNARLDCN-ZDUSSCGKSA-N 0.000 description 1
KRUKLTLGPIREQA-ZDUSSCGKSA-N 2-[(1s)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-8-chloro-n-[(3-propan-2-yl-1,2-oxazol-5-yl)methyl]quinoline-3-carboxamide Chemical compound O1N=C(C(C)C)C=C1CNC(=O)C1=CC2=CC=CC(Cl)=C2N=C1[C@H](C)NC1=NC=NC(N)=C1C#N KRUKLTLGPIREQA-ZDUSSCGKSA-N 0.000 description 1
LNOXDUZNQOHZDL-JTQLQIEISA-N 2-[(1s)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-8-chloro-n-cyclopropylquinoline-3-carboxamide Chemical compound N([C@@H](C)C=1C(=CC2=CC=CC(Cl)=C2N=1)C(=O)NC1CC1)C1=NC=NC(N)=C1C#N LNOXDUZNQOHZDL-JTQLQIEISA-N 0.000 description 1
HOKAXCDNRMMCRF-VIFPVBQESA-N 2-[(1s)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-8-chloro-n-methylquinoline-3-carboxamide Chemical compound N([C@@H](C)C1=NC2=C(Cl)C=CC=C2C=C1C(=O)NC)C1=NC=NC(N)=C1C#N HOKAXCDNRMMCRF-VIFPVBQESA-N 0.000 description 1
CNVZVIDPRAHPHF-NSHDSACASA-N 2-[(1s)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-8-chloro-n-propan-2-ylquinoline-3-carboxamide Chemical compound N([C@@H](C)C1=NC2=C(Cl)C=CC=C2C=C1C(=O)NC(C)C)C1=NC=NC(N)=C1C#N CNVZVIDPRAHPHF-NSHDSACASA-N 0.000 description 1
GDZDOICWCQENDJ-ZDUSSCGKSA-N 2-[(1s)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-n-[(2,5-dimethylpyrazol-3-yl)methyl]-6-fluoroquinoline-3-carboxamide Chemical compound N([C@@H](C)C=1C(=CC2=CC(F)=CC=C2N=1)C(=O)NCC=1N(N=C(C)C=1)C)C1=NC=NC(N)=C1C#N GDZDOICWCQENDJ-ZDUSSCGKSA-N 0.000 description 1
BWWUIQFGPVIQCW-JTQLQIEISA-N 2-[(1s)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-n-ethyl-8-fluoroquinoline-3-carboxamide Chemical compound N([C@@H](C)C1=NC2=C(F)C=CC=C2C=C1C(=O)NCC)C1=NC=NC(N)=C1C#N BWWUIQFGPVIQCW-JTQLQIEISA-N 0.000 description 1
QVHJQCGUWFKTSE-UHFFFAOYSA-N 2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound OC(=O)C(C)NC(=O)OC(C)(C)C QVHJQCGUWFKTSE-UHFFFAOYSA-N 0.000 description 1
IGFWVSIGFQOPTE-UHFFFAOYSA-N 2-[1-(3-cyclopropyl-6-fluoro-4-methoxyquinolin-2-yl)ethyl]isoindole-1,3-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1C(C)C1=NC2=CC=C(F)C=C2C(OC)=C1C1CC1 IGFWVSIGFQOPTE-UHFFFAOYSA-N 0.000 description 1
MIYWXRTYCDNMFX-UHFFFAOYSA-N 2-[1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-3-ethoxy-6-fluoro-n,n-dimethylquinoline-4-carboxamide Chemical compound N1=C2C=CC(F)=CC2=C(C(=O)N(C)C)C(OCC)=C1C(C)NC1=NC=NC(N)=C1C#N MIYWXRTYCDNMFX-UHFFFAOYSA-N 0.000 description 1
YXQQAQJZSWQDNH-UHFFFAOYSA-N 2-[1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-6-fluoro-3-methoxy-n,n-dimethylquinoline-4-carboxamide Chemical compound N1=C2C=CC(F)=CC2=C(C(=O)N(C)C)C(OC)=C1C(C)NC1=NC=NC(N)=C1C#N YXQQAQJZSWQDNH-UHFFFAOYSA-N 0.000 description 1
VCTFUWNDMYEPPM-UHFFFAOYSA-N 2-[1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-6-fluoro-3-methoxy-n-methylquinoline-4-carboxamide Chemical compound N=1C2=CC=C(F)C=C2C(C(=O)NC)=C(OC)C=1C(C)NC1=NC=NC(N)=C1C#N VCTFUWNDMYEPPM-UHFFFAOYSA-N 0.000 description 1
OQNQSYVHGUXDNM-UHFFFAOYSA-N 2-[1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-6-fluoro-n,n-dimethyl-3-propan-2-yloxyquinoline-4-carboxamide Chemical compound N1=C2C=CC(F)=CC2=C(C(=O)N(C)C)C(OC(C)C)=C1C(C)NC1=NC=NC(N)=C1C#N OQNQSYVHGUXDNM-UHFFFAOYSA-N 0.000 description 1
YDKDKZOUZPYZTK-UHFFFAOYSA-N 2-[1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-n-benzyl-8-fluoroquinoline-3-carboxamide Chemical compound N=1C2=C(F)C=CC=C2C=C(C(=O)NCC=2C=CC=CC=2)C=1C(C)NC1=NC=NC(N)=C1C#N YDKDKZOUZPYZTK-UHFFFAOYSA-N 0.000 description 1
RWSFZKWMVWPDGZ-UHFFFAOYSA-N 2-amino-6-fluorobenzoic acid Chemical compound NC1=CC=CC(F)=C1C(O)=O RWSFZKWMVWPDGZ-UHFFFAOYSA-N 0.000 description 1
QKJAZPHKNWSXDF-UHFFFAOYSA-N 2-bromoquinoline Chemical compound C1=CC=CC2=NC(Br)=CC=C21 QKJAZPHKNWSXDF-UHFFFAOYSA-N 0.000 description 1
FVFRNLGDLCSIAZ-UHFFFAOYSA-N 2-chloro-N-ethylquinoline-3-carboxamide Chemical compound ClC1=NC2=CC=CC=C2C=C1C(=O)NCC FVFRNLGDLCSIAZ-UHFFFAOYSA-N 0.000 description 1
FXQSUQZXESNFNH-UHFFFAOYSA-N 2-chloropyrimidine-5-carbonitrile Chemical compound ClC1=NC=C(C#N)C=N1 FXQSUQZXESNFNH-UHFFFAOYSA-N 0.000 description 1
XFSORZYTTCOBFN-UHFFFAOYSA-N 2-chloroquinoline-3-carboxylic acid Chemical compound C1=CC=C2N=C(Cl)C(C(=O)O)=CC2=C1 XFSORZYTTCOBFN-UHFFFAOYSA-N 0.000 description 1
YZJSARUCMYJHNV-UHFFFAOYSA-N 2-dimethylsilylethyl(dimethyl)silane Chemical group C[SiH](C)CC[SiH](C)C YZJSARUCMYJHNV-UHFFFAOYSA-N 0.000 description 1
XUGNJOCQALIQFG-UHFFFAOYSA-N 2-ethenylquinoline Chemical compound C1=CC=CC2=NC(C=C)=CC=C21 XUGNJOCQALIQFG-UHFFFAOYSA-N 0.000 description 1
YBDQLHBVNXARAU-UHFFFAOYSA-N 2-methyloxane Chemical compound CC1CCCCO1 YBDQLHBVNXARAU-UHFFFAOYSA-N 0.000 description 1
229940080296 2-naphthalenesulfonate Drugs 0.000 description 1
LHGWJCBYBIICPP-UHFFFAOYSA-N 2-oxobutyl acetate Chemical compound CCC(=O)COC(C)=O LHGWJCBYBIICPP-UHFFFAOYSA-N 0.000 description 1
WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
WMPPDTMATNBGJN-UHFFFAOYSA-N 2-phenylethylbromide Chemical class BrCCC1=CC=CC=C1 WMPPDTMATNBGJN-UHFFFAOYSA-N 0.000 description 1
LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
NGZVNONVXYLYQW-UHFFFAOYSA-N 3,3,3-trifluoropropan-1-amine Chemical compound NCCC(F)(F)F NGZVNONVXYLYQW-UHFFFAOYSA-N 0.000 description 1
BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
IDHRGNLSOGKOHF-UHFFFAOYSA-N 3-bromo-2-(1-bromoethyl)-6-fluoro-4-methoxyquinoline Chemical compound C1=C(F)C=C2C(OC)=C(Br)C(C(C)Br)=NC2=C1 IDHRGNLSOGKOHF-UHFFFAOYSA-N 0.000 description 1
UZXFVCSBFTZRHM-UHFFFAOYSA-N 3-bromo-2-ethyl-6-fluoro-4-methylsulfanylquinoline Chemical compound C1=C(F)C=C2C(SC)=C(Br)C(CC)=NC2=C1 UZXFVCSBFTZRHM-UHFFFAOYSA-N 0.000 description 1
ZRPLANDPDWYOMZ-UHFFFAOYSA-N 3-cyclopentylpropionic acid Chemical compound OC(=O)CCC1CCCC1 ZRPLANDPDWYOMZ-UHFFFAOYSA-N 0.000 description 1
CAUXQOLTFGCRKD-UHFFFAOYSA-N 4,4-dimethylcyclohexan-1-amine Chemical compound CC1(C)CCC(N)CC1 CAUXQOLTFGCRKD-UHFFFAOYSA-N 0.000 description 1
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
QGHDLJAZIIFENW-UHFFFAOYSA-N 4-[1,1,1,3,3,3-hexafluoro-2-(4-hydroxy-3-prop-2-enylphenyl)propan-2-yl]-2-prop-2-enylphenol Chemical group C1=C(CC=C)C(O)=CC=C1C(C(F)(F)F)(C(F)(F)F)C1=CC=C(O)C(CC=C)=C1 QGHDLJAZIIFENW-UHFFFAOYSA-N 0.000 description 1
IWMWYLJBOSCYFK-UHFFFAOYSA-N 4-amino-6-[1-[4-(3-aminoazetidine-1-carbonyl)-6-fluoro-3-methoxyquinolin-2-yl]ethylamino]pyrimidine-5-carbonitrile Chemical compound COC1=C(C(C)NC=2C(=C(N)N=CN=2)C#N)N=C2C=CC(F)=CC2=C1C(=O)N1CC(N)C1 IWMWYLJBOSCYFK-UHFFFAOYSA-N 0.000 description 1
OTJXNDPOVYPRFT-UHFFFAOYSA-N 4-amino-6-[1-[6-fluoro-3-methoxy-4-(morpholine-4-carbonyl)quinolin-2-yl]ethylamino]pyrimidine-5-carbonitrile Chemical compound COC1=C(C(C)NC=2C(=C(N)N=CN=2)C#N)N=C2C=CC(F)=CC2=C1C(=O)N1CCOCC1 OTJXNDPOVYPRFT-UHFFFAOYSA-N 0.000 description 1
UWDYNMLBFKTCHC-UHFFFAOYSA-N 4-amino-6-[1-[6-fluoro-3-methoxy-4-(piperazine-1-carbonyl)quinolin-2-yl]ethylamino]pyrimidine-5-carbonitrile Chemical compound COC1=C(C(C)NC=2C(=C(N)N=CN=2)C#N)N=C2C=CC(F)=CC2=C1C(=O)N1CCNCC1 UWDYNMLBFKTCHC-UHFFFAOYSA-N 0.000 description 1
ASTDKNJEDKQYQQ-SNVBAGLBSA-N 4-amino-6-[[(1r)-1-(3-cyclopropyl-6-fluoro-4-methoxyquinolin-2-yl)ethyl]amino]pyrimidine-5-carbonitrile Chemical compound C1([C@@H](C)NC=2C(=C(N)N=CN=2)C#N)=NC2=CC=C(F)C=C2C(OC)=C1C1CC1 ASTDKNJEDKQYQQ-SNVBAGLBSA-N 0.000 description 1
FCDOPWPLXFENHF-LBPRGKRZSA-N 4-amino-6-[[(1s)-1-[6-fluoro-4-oxo-3-(piperazin-1-ylmethyl)-1h-quinolin-2-yl]ethyl]amino]pyrimidine-5-carbonitrile Chemical compound N([C@@H](C)C=1C(=C(O)C2=CC(F)=CC=C2N=1)CN1CCNCC1)C1=NC=NC(N)=C1C#N FCDOPWPLXFENHF-LBPRGKRZSA-N 0.000 description 1
OYHRVKLZWJSGKL-LBPRGKRZSA-N 4-amino-6-[[(1s)-1-[8-fluoro-3-(morpholine-4-carbonyl)quinolin-2-yl]ethyl]amino]pyrimidine-5-carbonitrile Chemical compound N([C@@H](C)C=1C(=CC2=CC=CC(F)=C2N=1)C(=O)N1CCOCC1)C1=NC=NC(N)=C1C#N OYHRVKLZWJSGKL-LBPRGKRZSA-N 0.000 description 1
ZDVSOSPNNDNIDT-ZDUSSCGKSA-N 4-amino-6-[[(1s)-1-[8-fluoro-3-(piperidine-1-carbonyl)quinolin-2-yl]ethyl]amino]pyrimidine-5-carbonitrile Chemical compound N([C@@H](C)C=1C(=CC2=CC=CC(F)=C2N=1)C(=O)N1CCCCC1)C1=NC=NC(N)=C1C#N ZDVSOSPNNDNIDT-ZDUSSCGKSA-N 0.000 description 1
UZOVYGYOLBIAJR-UHFFFAOYSA-N 4-isocyanato-4'-methyldiphenylmethane Chemical compound C1=CC(C)=CC=C1CC1=CC=C(N=C=O)C=C1 UZOVYGYOLBIAJR-UHFFFAOYSA-N 0.000 description 1
MJRKZPRJYPQZQY-UHFFFAOYSA-N 4-methyl-3-propan-2-yl-1,2-oxazole Chemical compound CC(C)C1=NOC=C1C MJRKZPRJYPQZQY-UHFFFAOYSA-N 0.000 description 1
DDFHBQSCUXNBSA-UHFFFAOYSA-N 5-(5-carboxythiophen-2-yl)thiophene-2-carboxylic acid Chemical compound S1C(C(=O)O)=CC=C1C1=CC=C(C(O)=O)S1 DDFHBQSCUXNBSA-UHFFFAOYSA-N 0.000 description 1
GKODDAXOSGGARJ-UHFFFAOYSA-N 5-Fluoroisatin Chemical compound FC1=CC=C2NC(=O)C(=O)C2=C1 GKODDAXOSGGARJ-UHFFFAOYSA-N 0.000 description 1
FPQMGQZTBWIHDN-UHFFFAOYSA-N 5-fluoroanthranilic acid Chemical compound NC1=CC=C(F)C=C1C(O)=O FPQMGQZTBWIHDN-UHFFFAOYSA-N 0.000 description 1
ZUWWXKNSSWMDLE-UHFFFAOYSA-N 5-fluoroquinoline-3-carboxamide Chemical compound FC1=C2C=C(C=NC2=CC=C1)C(=O)N ZUWWXKNSSWMDLE-UHFFFAOYSA-N 0.000 description 1
XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
SFHYNDMGZXWXBU-LIMNOBDPSA-N 6-amino-2-[[(e)-(3-formylphenyl)methylideneamino]carbamoylamino]-1,3-dioxobenzo[de]isoquinoline-5,8-disulfonic acid Chemical compound O=C1C(C2=3)=CC(S(O)(=O)=O)=CC=3C(N)=C(S(O)(=O)=O)C=C2C(=O)N1NC(=O)N\N=C\C1=CC=CC(C=O)=C1 SFHYNDMGZXWXBU-LIMNOBDPSA-N 0.000 description 1
FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
YUDXFKPYVZUMPM-UHFFFAOYSA-N 7H-purine 1H-quinazolin-2-one Chemical compound C1=NC=C2NC=NC2=N1.C1=CC=C2NC(=O)N=CC2=C1 YUDXFKPYVZUMPM-UHFFFAOYSA-N 0.000 description 1
CPRAGQJXBLMUEL-UHFFFAOYSA-N 9-(1-anilinoethyl)-7-methyl-2-(4-morpholinyl)-4-pyrido[1,2-a]pyrimidinone Chemical compound C=1C(C)=CN(C(C=C(N=2)N3CCOCC3)=O)C=2C=1C(C)NC1=CC=CC=C1 CPRAGQJXBLMUEL-UHFFFAOYSA-N 0.000 description 1
QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
108091006112 ATPases Proteins 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
206010002198 Anaphylactic reaction Diseases 0.000 description 1
206010002388 Angina unstable Diseases 0.000 description 1
206010003594 Ataxia telangiectasia Diseases 0.000 description 1
201000001320 Atherosclerosis Diseases 0.000 description 1
108091008875 B cell receptors Proteins 0.000 description 1
102000019260 B-Cell Antigen Receptors Human genes 0.000 description 1
108010012919 B-Cell Antigen Receptors Proteins 0.000 description 1
230000003844 B-cell-activation Effects 0.000 description 1
238000011725 BALB/c mouse Methods 0.000 description 1
206010005003 Bladder cancer Diseases 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
ODHFJIDDBSDWNU-UHFFFAOYSA-N CCCC[Mg]CCCC Chemical compound CCCC[Mg]CCCC ODHFJIDDBSDWNU-UHFFFAOYSA-N 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
OKTJSMMVPCPJKN-NJFSPNSNSA-N Carbon-14 Chemical compound [14C] OKTJSMMVPCPJKN-NJFSPNSNSA-N 0.000 description 1
201000009030 Carcinoma Diseases 0.000 description 1
208000024172 Cardiovascular disease Diseases 0.000 description 1
102000000844 Cell Surface Receptors Human genes 0.000 description 1
108010001857 Cell Surface Receptors Proteins 0.000 description 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
108091007959 Class II PI3Ks Proteins 0.000 description 1
108091007963 Class III PI3Ks Proteins 0.000 description 1
206010053567 Coagulopathies Diseases 0.000 description 1
101100007328 Cocos nucifera COS-1 gene Proteins 0.000 description 1
206010009944 Colon cancer Diseases 0.000 description 1
108090000695 Cytokines Proteins 0.000 description 1
102000004127 Cytokines Human genes 0.000 description 1
206010051055 Deep vein thrombosis Diseases 0.000 description 1
YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
101001024630 Drosophila melanogaster RNA cytidine acetyltransferase Proteins 0.000 description 1
101000652705 Drosophila melanogaster Transcription initiation factor TFIID subunit 4 Proteins 0.000 description 1
238000012286 ELISA Assay Methods 0.000 description 1
208000005189 Embolism Diseases 0.000 description 1
206010014733 Endometrial cancer Diseases 0.000 description 1
206010014759 Endometrial neoplasm Diseases 0.000 description 1
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
102100035421 Forkhead box protein O3 Human genes 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
208000032612 Glial tumor Diseases 0.000 description 1
206010018338 Glioma Diseases 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
208000002705 Glucose Intolerance Diseases 0.000 description 1
206010018429 Glucose tolerance impaired Diseases 0.000 description 1
102000009465 Growth Factor Receptors Human genes 0.000 description 1
108010009202 Growth Factor Receptors Proteins 0.000 description 1
SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
102100026122 High affinity immunoglobulin gamma Fc receptor I Human genes 0.000 description 1
241000282412 Homo Species 0.000 description 1
101000897480 Homo sapiens C-C motif chemokine 2 Proteins 0.000 description 1
101000877681 Homo sapiens Forkhead box protein O3 Proteins 0.000 description 1
101000913074 Homo sapiens High affinity immunoglobulin gamma Fc receptor I Proteins 0.000 description 1
101000605630 Homo sapiens Phosphatidylinositol 3-kinase catalytic subunit type 3 Proteins 0.000 description 1
101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 1
101001059443 Homo sapiens Serine/threonine-protein kinase MARK1 Proteins 0.000 description 1
101001059454 Homo sapiens Serine/threonine-protein kinase MARK2 Proteins 0.000 description 1
206010060378 Hyperinsulinaemia Diseases 0.000 description 1
206010020710 Hyperphagia Diseases 0.000 description 1
206010020772 Hypertension Diseases 0.000 description 1
206010058002 Hypoglobulinaemia Diseases 0.000 description 1
101150088952 IGF1 gene Proteins 0.000 description 1
206010061598 Immunodeficiency Diseases 0.000 description 1
208000029462 Immunodeficiency disease Diseases 0.000 description 1
102000003746 Insulin Receptor Human genes 0.000 description 1
108010001127 Insulin Receptor Proteins 0.000 description 1
108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
108010002616 Interleukin-5 Proteins 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
235000010643 Leucaena leucocephala Nutrition 0.000 description 1
240000007472 Leucaena leucocephala Species 0.000 description 1
206010025323 Lymphomas Diseases 0.000 description 1
208000030289 Lymphoproliferative disease Diseases 0.000 description 1
206010064912 Malignant transformation Diseases 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
239000012359 Methanesulfonyl chloride Substances 0.000 description 1
241001529936 Murinae Species 0.000 description 1
101000897464 Mus musculus C-C motif chemokine 2 Proteins 0.000 description 1
NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical group ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
108010025020 Nerve Growth Factor Proteins 0.000 description 1
PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
239000005642 Oleic acid Substances 0.000 description 1
ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
108700020796 Oncogene Proteins 0.000 description 1
108010058846 Ovalbumin Proteins 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
235000019483 Peanut oil Nutrition 0.000 description 1
102000003992 Peroxidases Human genes 0.000 description 1
102100038329 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human genes 0.000 description 1
102100036052 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human genes 0.000 description 1
101710096503 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Proteins 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
239000004372 Polyvinyl alcohol Substances 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
206010060862 Prostate cancer Diseases 0.000 description 1
208000000236 Prostatic Neoplasms Diseases 0.000 description 1
208000010378 Pulmonary Embolism Diseases 0.000 description 1
IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
101710113459 RAC-alpha serine/threonine-protein kinase Proteins 0.000 description 1
239000012980 RPMI-1640 medium Substances 0.000 description 1
102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 1
208000006265 Renal cell carcinoma Diseases 0.000 description 1
108010034782 Ribosomal Protein S6 Kinases Proteins 0.000 description 1
102000009738 Ribosomal Protein S6 Kinases Human genes 0.000 description 1
102000014400 SH2 domains Human genes 0.000 description 1
108050003452 SH2 domains Proteins 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
101000996915 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Nucleoporin NSP1 Proteins 0.000 description 1
108010031271 Saccharomyces cerevisiae Proteins Proteins 0.000 description 1
102100028904 Serine/threonine-protein kinase MARK2 Human genes 0.000 description 1
XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
206010041067 Small cell lung cancer Diseases 0.000 description 1
102100035748 Squamous cell carcinoma antigen recognized by T-cells 3 Human genes 0.000 description 1
235000021355 Stearic acid Nutrition 0.000 description 1
208000006011 Stroke Diseases 0.000 description 1
OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
108010092262 T-Cell Antigen Receptors Proteins 0.000 description 1
102000042834 TEC family Human genes 0.000 description 1
108091082333 TEC family Proteins 0.000 description 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
108090000190 Thrombin Proteins 0.000 description 1
208000001435 Thromboembolism Diseases 0.000 description 1
208000007536 Thrombosis Diseases 0.000 description 1
208000033781 Thyroid carcinoma Diseases 0.000 description 1
208000024770 Thyroid neoplasm Diseases 0.000 description 1
229920001615 Tragacanth Polymers 0.000 description 1
208000007814 Unstable Angina Diseases 0.000 description 1
206010047249 Venous thrombosis Diseases 0.000 description 1
ZSZXYWFCIKKZBT-ZVDPZPSOSA-N [(2r)-3-[[(2s,3s,5r,6s)-2,6-dihydroxy-3,4,5-triphosphonooxycyclohexyl]oxy-hydroxyphosphoryl]oxy-2-hexadecanoyloxypropyl] hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCC)COP(O)(=O)OC1[C@H](O)[C@H](OP(O)(O)=O)C(OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H]1O ZSZXYWFCIKKZBT-ZVDPZPSOSA-N 0.000 description 1
MUUXBTFQEXVEEI-UHFFFAOYSA-N [2-(dimethyl-$l^{3}-silanyl)phenyl]-dimethylsilicon Chemical group C[Si](C)C1=CC=CC=C1[Si](C)C MUUXBTFQEXVEEI-UHFFFAOYSA-N 0.000 description 1
230000001594 aberrant effect Effects 0.000 description 1
125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
238000005903 acid hydrolysis reaction Methods 0.000 description 1
239000008186 active pharmaceutical agent Substances 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
125000004442 acylamino group Chemical group 0.000 description 1
102000035181 adaptor proteins Human genes 0.000 description 1
108091005764 adaptor proteins Proteins 0.000 description 1
WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
208000037883 airway inflammation Diseases 0.000 description 1
125000003158 alcohol group Chemical group 0.000 description 1
229940072056 alginate Drugs 0.000 description 1
235000010443 alginic acid Nutrition 0.000 description 1
229920000615 alginic acid Polymers 0.000 description 1
229910052783 alkali metal Inorganic materials 0.000 description 1
150000001340 alkali metals Chemical class 0.000 description 1
150000001447 alkali salts Chemical class 0.000 description 1
229910052784 alkaline earth metal Inorganic materials 0.000 description 1
150000001342 alkaline earth metals Chemical class 0.000 description 1
125000005197 alkyl carbonyloxy alkyl group Chemical group 0.000 description 1
125000000217 alkyl group Chemical group 0.000 description 1
150000001350 alkyl halides Chemical class 0.000 description 1
208000037884 allergic airway inflammation Diseases 0.000 description 1
230000007815 allergy Effects 0.000 description 1
AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
150000001414 amino alcohols Chemical class 0.000 description 1
229910021529 ammonia Inorganic materials 0.000 description 1
150000003863 ammonium salts Chemical class 0.000 description 1
230000003321 amplification Effects 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
230000036783 anaphylactic response Effects 0.000 description 1
208000003455 anaphylaxis Diseases 0.000 description 1
125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
239000003146 anticoagulant agent Substances 0.000 description 1
125000003710 aryl alkyl group Chemical group 0.000 description 1
229940009098 aspartate Drugs 0.000 description 1
239000000305 astragalus gummifer gum Substances 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
230000002238 attenuated effect Effects 0.000 description 1
230000001363 autoimmune Effects 0.000 description 1
125000000043 benzamido group Chemical group [H]N([*])C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
229940077388 benzenesulfonate Drugs 0.000 description 1
SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
FHCIILYMWWRNIZ-UHFFFAOYSA-N benzhydryl(chloro)silane Chemical compound C=1C=CC=CC=1C([SiH2]Cl)C1=CC=CC=C1 FHCIILYMWWRNIZ-UHFFFAOYSA-N 0.000 description 1
125000005605 benzo group Chemical group 0.000 description 1
229940050390 benzoate Drugs 0.000 description 1
229960004365 benzoic acid Drugs 0.000 description 1
WGNZRLMOMHJUSP-UHFFFAOYSA-N benzotriazol-1-yloxy(tripyrrolidin-1-yl)phosphanium Chemical compound C1CCCN1[P+](N1CCCC1)(N1CCCC1)ON1C2=CC=CC=C2N=N1 WGNZRLMOMHJUSP-UHFFFAOYSA-N 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
MUALRAIOVNYAIW-UHFFFAOYSA-N binap Chemical compound C1=CC=CC=C1P(C=1C(=C2C=CC=CC2=CC=1)C=1C2=CC=CC=C2C=CC=1P(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 MUALRAIOVNYAIW-UHFFFAOYSA-N 0.000 description 1
238000004166 bioassay Methods 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
230000029918 bioluminescence Effects 0.000 description 1
238000005415 bioluminescence Methods 0.000 description 1
239000000090 biomarker Substances 0.000 description 1
230000036983 biotransformation Effects 0.000 description 1
201000001531 bladder carcinoma Diseases 0.000 description 1
230000036765 blood level Effects 0.000 description 1
210000002798 bone marrow cell Anatomy 0.000 description 1
210000005013 brain tissue Anatomy 0.000 description 1
210000000481 breast Anatomy 0.000 description 1
206010006451 bronchitis Diseases 0.000 description 1
239000006172 buffering agent Substances 0.000 description 1
235000019437 butane-1,3-diol Nutrition 0.000 description 1
KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000011575 calcium Substances 0.000 description 1
159000000007 calcium salts Chemical class 0.000 description 1
MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical compound C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 description 1
VNWKTOKETHGBQD-AKLPVKDBSA-N carbane Chemical group [15CH4] VNWKTOKETHGBQD-AKLPVKDBSA-N 0.000 description 1
150000007942 carboxylates Chemical class 0.000 description 1
230000000747 cardiac effect Effects 0.000 description 1
238000012754 cardiac puncture Methods 0.000 description 1
150000001768 cations Chemical class 0.000 description 1
230000020411 cell activation Effects 0.000 description 1
230000011712 cell development Effects 0.000 description 1
230000024245 cell differentiation Effects 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
230000012292 cell migration Effects 0.000 description 1
238000001516 cell proliferation assay Methods 0.000 description 1
239000006285 cell suspension Substances 0.000 description 1
230000033077 cellular process Effects 0.000 description 1
230000036755 cellular response Effects 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
KWYZNESIGBQHJK-UHFFFAOYSA-N chloro-dimethyl-phenylsilane Chemical compound C[Si](C)(Cl)C1=CC=CC=C1 KWYZNESIGBQHJK-UHFFFAOYSA-N 0.000 description 1
IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 1
229940001468 citrate Drugs 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
230000004186 co-expression Effects 0.000 description 1
229940110456 cocoa butter Drugs 0.000 description 1
235000019868 cocoa butter Nutrition 0.000 description 1
208000029742 colonic neoplasm Diseases 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
239000002285 corn oil Substances 0.000 description 1
235000005687 corn oil Nutrition 0.000 description 1
208000029078 coronary artery disease Diseases 0.000 description 1
230000000139 costimulatory effect Effects 0.000 description 1
235000012343 cottonseed oil Nutrition 0.000 description 1
239000002385 cottonseed oil Substances 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
239000006071 cream Substances 0.000 description 1
239000013058 crude material Substances 0.000 description 1
239000012045 crude solution Substances 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
125000004122 cyclic group Chemical group 0.000 description 1
125000000392 cycloalkenyl group Chemical group 0.000 description 1
125000000753 cycloalkyl group Chemical group 0.000 description 1
WLVKDFJTYKELLQ-UHFFFAOYSA-N cyclopropylboronic acid Chemical compound OB(O)C1CC1 WLVKDFJTYKELLQ-UHFFFAOYSA-N 0.000 description 1
210000000172 cytosol Anatomy 0.000 description 1
DEZRYPDIMOWBDS-UHFFFAOYSA-N dcm dichloromethane Chemical compound ClCCl.ClCCl DEZRYPDIMOWBDS-UHFFFAOYSA-N 0.000 description 1
125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
230000002950 deficient Effects 0.000 description 1
238000001514 detection method Methods 0.000 description 1
229910052805 deuterium Inorganic materials 0.000 description 1
239000008121 dextrose Substances 0.000 description 1
150000008050 dialkyl sulfates Chemical class 0.000 description 1
239000002027 dichloromethane extract Substances 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
238000005906 dihydroxylation reaction Methods 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
UXGNZZKBCMGWAZ-UHFFFAOYSA-N dimethylformamide dmf Chemical compound CN(C)C=O.CN(C)C=O UXGNZZKBCMGWAZ-UHFFFAOYSA-N 0.000 description 1
GAFRWLVTHPVQGK-UHFFFAOYSA-N dipentyl sulfate Chemical class CCCCCOS(=O)(=O)OCCCCC GAFRWLVTHPVQGK-UHFFFAOYSA-N 0.000 description 1
ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical group C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
208000037765 diseases and disorders Diseases 0.000 description 1
KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical group [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
239000002270 dispersing agent Substances 0.000 description 1
238000004821 distillation Methods 0.000 description 1
125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
229940043264 dodecyl sulfate Drugs 0.000 description 1
230000004064 dysfunction Effects 0.000 description 1
239000012636 effector Substances 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
238000003821 enantio-separation Methods 0.000 description 1
201000003914 endometrial carcinoma Diseases 0.000 description 1
210000001163 endosome Anatomy 0.000 description 1
239000002702 enteric coating Substances 0.000 description 1
238000009505 enteric coating Methods 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
238000001952 enzyme assay Methods 0.000 description 1
125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
125000005448 ethoxyethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 description 1
HYCJHUIEDYVJKL-UHFFFAOYSA-N ethyl 2-[1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-3-ethoxy-6-fluoroquinoline-4-carboxylate Chemical compound N=1C2=CC=C(F)C=C2C(C(=O)OCC)=C(OCC)C=1C(C)NC1=NC=NC(N)=C1C#N HYCJHUIEDYVJKL-UHFFFAOYSA-N 0.000 description 1
FJNPSCMPIMJRJR-NSHDSACASA-N ethyl 5-fluoro-2-[(1s)-1-[(2-methylpropan-2-yl)oxycarbonylamino]ethyl]quinoline-3-carboxylate Chemical compound C1=CC=C2N=C([C@H](C)NC(=O)OC(C)(C)C)C(C(=O)OCC)=CC2=C1F FJNPSCMPIMJRJR-NSHDSACASA-N 0.000 description 1
IXVIHAKXYIIPEG-NSHDSACASA-N ethyl 6-fluoro-2-[(1s)-1-[(2-methylpropan-2-yl)oxycarbonylamino]ethyl]quinoline-3-carboxylate Chemical compound FC1=CC=C2N=C([C@H](C)NC(=O)OC(C)(C)C)C(C(=O)OCC)=CC2=C1 IXVIHAKXYIIPEG-NSHDSACASA-N 0.000 description 1
PYIONCIEWALFEN-NSHDSACASA-N ethyl 8-chloro-2-[(1s)-1-[(2-methylpropan-2-yl)oxycarbonylamino]ethyl]quinoline-3-carboxylate Chemical compound C1=CC(Cl)=C2N=C([C@H](C)NC(=O)OC(C)(C)C)C(C(=O)OCC)=CC2=C1 PYIONCIEWALFEN-NSHDSACASA-N 0.000 description 1
LIWAQLJGPBVORC-UHFFFAOYSA-N ethylmethylamine Chemical compound CCNC LIWAQLJGPBVORC-UHFFFAOYSA-N 0.000 description 1
125000006351 ethylthiomethyl group Chemical group [H]C([H])([H])C([H])([H])SC([H])([H])* 0.000 description 1
239000013604 expression vector Substances 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
239000012065 filter cake Substances 0.000 description 1
239000000796 flavoring agent Substances 0.000 description 1
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
238000002376 fluorescence recovery after photobleaching Methods 0.000 description 1
239000011737 fluorine Substances 0.000 description 1
238000011010 flushing procedure Methods 0.000 description 1
235000019253 formic acid Nutrition 0.000 description 1
239000012634 fragment Substances 0.000 description 1
239000012458 free base Substances 0.000 description 1
238000004108 freeze drying Methods 0.000 description 1
239000001530 fumaric acid Substances 0.000 description 1
235000011087 fumaric acid Nutrition 0.000 description 1
102000037865 fusion proteins Human genes 0.000 description 1
108020001507 fusion proteins Proteins 0.000 description 1
238000003304 gavage Methods 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
208000005017 glioblastoma Diseases 0.000 description 1
125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
229940075507 glyceryl monostearate Drugs 0.000 description 1
230000036433 growing body Effects 0.000 description 1
239000003102 growth factor Substances 0.000 description 1
ZRALSGWEFCBTJO-UHFFFAOYSA-N guanidine group Chemical group NC(=N)N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 1
150000002367 halogens Chemical class 0.000 description 1
230000004217 heart function Effects 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
206010073071 hepatocellular carcinoma Diseases 0.000 description 1
MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 1
125000001072 heteroaryl group Chemical group 0.000 description 1
239000000833 heterodimer Substances 0.000 description 1
102000034345 heterotrimeric G proteins Human genes 0.000 description 1
108091006093 heterotrimeric G proteins Proteins 0.000 description 1
FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
102000046768 human CCL2 Human genes 0.000 description 1
102000053508 human MARK1 Human genes 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
150000004677 hydrates Chemical class 0.000 description 1
YPGCWEMNNLXISK-UHFFFAOYSA-N hydratropic acid Chemical compound OC(=O)C(C)C1=CC=CC=C1 YPGCWEMNNLXISK-UHFFFAOYSA-N 0.000 description 1
BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
230000003301 hydrolyzing effect Effects 0.000 description 1
125000004356 hydroxy functional group Chemical group O* 0.000 description 1
RCBVKBFIWMOMHF-UHFFFAOYSA-L hydroxy-(hydroxy(dioxo)chromio)oxy-dioxochromium;pyridine Chemical compound C1=CC=NC=C1.C1=CC=NC=C1.O[Cr](=O)(=O)O[Cr](O)(=O)=O RCBVKBFIWMOMHF-UHFFFAOYSA-L 0.000 description 1
201000001421 hyperglycemia Diseases 0.000 description 1
230000035879 hyperinsulinaemia Effects 0.000 description 1
210000002865 immune cell Anatomy 0.000 description 1
230000028993 immune response Effects 0.000 description 1
230000007813 immunodeficiency Effects 0.000 description 1
239000003018 immunosuppressive agent Substances 0.000 description 1
229940125721 immunosuppressive agent Drugs 0.000 description 1
230000001771 impaired effect Effects 0.000 description 1
239000012535 impurity Substances 0.000 description 1
238000005462 in vivo assay Methods 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 1
230000028709 inflammatory response Effects 0.000 description 1
238000001802 infusion Methods 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
229940102223 injectable solution Drugs 0.000 description 1
229940102213 injectable suspension Drugs 0.000 description 1
210000005007 innate immune system Anatomy 0.000 description 1
229960000367 inositol Drugs 0.000 description 1
201000004332 intermediate coronary syndrome Diseases 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
208000028867 ischemia Diseases 0.000 description 1
SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
125000006352 iso-propylthiomethyl group Chemical group [H]C([H])([H])C([H])(SC([H])([H])*)C([H])([H])[H] 0.000 description 1
125000005929 isobutyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])OC(*)=O 0.000 description 1
239000012948 isocyanate Substances 0.000 description 1
150000002513 isocyanates Chemical class 0.000 description 1
QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
125000006229 isopropoxyethyl group Chemical group [H]C([H])([H])C([H])(OC([H])([H])C([H])([H])*)C([H])([H])[H] 0.000 description 1
210000003292 kidney cell Anatomy 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
239000000865 liniment Substances 0.000 description 1
125000005647 linker group Chemical group 0.000 description 1
239000008297 liquid dosage form Substances 0.000 description 1
208000014018 liver neoplasm Diseases 0.000 description 1
239000006210 lotion Substances 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
210000004698 lymphocyte Anatomy 0.000 description 1
230000002934 lysing effect Effects 0.000 description 1
229910001629 magnesium chloride Inorganic materials 0.000 description 1
239000000395 magnesium oxide Substances 0.000 description 1
CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
FYYHWMGAXLPEAU-OUBTZVSYSA-N magnesium-25 atom Chemical compound [25Mg] FYYHWMGAXLPEAU-OUBTZVSYSA-N 0.000 description 1
KJJBSBKRXUVBMX-UHFFFAOYSA-N magnesium;butane Chemical compound [Mg+2].CCC[CH2-].CCC[CH2-] KJJBSBKRXUVBMX-UHFFFAOYSA-N 0.000 description 1
AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
125000005439 maleimidyl group Chemical group C1(C=CC(N1*)=O)=O 0.000 description 1
239000001630 malic acid Substances 0.000 description 1
235000011090 malic acid Nutrition 0.000 description 1
230000036212 malign transformation Effects 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
229960002510 mandelic acid Drugs 0.000 description 1
210000003826 marginal zone b cell Anatomy 0.000 description 1
210000002752 melanocyte Anatomy 0.000 description 1
201000001441 melanoma Diseases 0.000 description 1
239000012528 membrane Substances 0.000 description 1
108020004999 messenger RNA Proteins 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
229910000000 metal hydroxide Inorganic materials 0.000 description 1
150000004692 metal hydroxides Chemical class 0.000 description 1
AFVFQIVMOAPDHO-UHFFFAOYSA-M methanesulfonate group Chemical group CS(=O)(=O)[O-] AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 1
229940098779 methanesulfonic acid Drugs 0.000 description 1
QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
RUZLIIJDZBWWSA-INIZCTEOSA-N methyl 2-[[(1s)-1-(7-methyl-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidin-9-yl)ethyl]amino]benzoate Chemical group COC(=O)C1=CC=CC=C1N[C@@H](C)C1=CC(C)=CN2C(=O)C=C(N3CCOCC3)N=C12 RUZLIIJDZBWWSA-INIZCTEOSA-N 0.000 description 1
125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
125000004092 methylthiomethyl group Chemical group [H]C([H])([H])SC([H])([H])* 0.000 description 1
230000001617 migratory effect Effects 0.000 description 1
239000003226 mitogen Substances 0.000 description 1
230000002297 mitogenic effect Effects 0.000 description 1
238000002156 mixing Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
239000002808 molecular sieve Substances 0.000 description 1
239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
208000010125 myocardial infarction Diseases 0.000 description 1
125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
CBIAEDGAYPAJMZ-UHFFFAOYSA-N n-[[2-(aminomethyl)-5-fluoroquinolin-3-yl]methyl]-n-ethylethanamine Chemical compound C1=CC=C2N=C(CN)C(CN(CC)CC)=CC2=C1F CBIAEDGAYPAJMZ-UHFFFAOYSA-N 0.000 description 1
AOTOAIFCUZOGTP-UHFFFAOYSA-N n-ethyl-2,3,4-trimethylpentan-3-amine Chemical compound CCNC(C)(C(C)C)C(C)C AOTOAIFCUZOGTP-UHFFFAOYSA-N 0.000 description 1
KVBGVZZKJNLNJU-UHFFFAOYSA-M naphthalene-2-sulfonate Chemical compound C1=CC=CC2=CC(S(=O)(=O)[O-])=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-M 0.000 description 1
125000001624 naphthyl group Chemical group 0.000 description 1
239000002858 neurotransmitter agent Substances 0.000 description 1
235000001968 nicotinic acid Nutrition 0.000 description 1
239000011664 nicotinic acid Substances 0.000 description 1
150000002825 nitriles Chemical class 0.000 description 1
231100000344 non-irritating Toxicity 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
230000000269 nucleophilic effect Effects 0.000 description 1
XURVRZSODRHRNK-UHFFFAOYSA-N o-quinodimethane Chemical compound C=C1C=CC=CC1=C XURVRZSODRHRNK-UHFFFAOYSA-N 0.000 description 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
239000002674 ointment Substances 0.000 description 1
ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
108091008819 oncoproteins Proteins 0.000 description 1
102000027450 oncoproteins Human genes 0.000 description 1
238000003305 oral gavage Methods 0.000 description 1
150000007530 organic bases Chemical class 0.000 description 1
229940092253 ovalbumin Drugs 0.000 description 1
230000002611 ovarian Effects 0.000 description 1
IPBPLHNLRKRLPJ-UHFFFAOYSA-N oxan-4-ylmethanamine Chemical compound NCC1CCOCC1 IPBPLHNLRKRLPJ-UHFFFAOYSA-N 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
239000006072 paste Substances 0.000 description 1
239000000312 peanut oil Substances 0.000 description 1
239000008188 pellet Substances 0.000 description 1
230000035515 penetration Effects 0.000 description 1
239000002304 perfume Substances 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
108040007629 peroxidase activity proteins Proteins 0.000 description 1
JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical compound [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
239000002831 pharmacologic agent Substances 0.000 description 1
125000001792 phenanthrenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
239000002935 phosphatidylinositol 3 kinase inhibitor Substances 0.000 description 1
XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 description 1
230000026731 phosphorylation Effects 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
125000005545 phthalimidyl group Chemical group 0.000 description 1
125000000612 phthaloyl group Chemical group C(C=1C(C(=O)*)=CC=CC1)(=O)* 0.000 description 1
229940075930 picrate Drugs 0.000 description 1
OXNIZHLAWKMVMX-UHFFFAOYSA-M picrate anion Chemical compound [O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-M 0.000 description 1
IUGYQRQAERSCNH-UHFFFAOYSA-M pivalate Chemical compound CC(C)(C)C([O-])=O IUGYQRQAERSCNH-UHFFFAOYSA-M 0.000 description 1
229950010765 pivalate Drugs 0.000 description 1
230000010118 platelet activation Effects 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
229920002451 polyvinyl alcohol Polymers 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
239000011591 potassium Substances 0.000 description 1
FYRHIOVKTDQVFC-UHFFFAOYSA-M potassium phthalimide Chemical compound [K+].C1=CC=C2C(=O)[N-]C(=O)C2=C1 FYRHIOVKTDQVFC-UHFFFAOYSA-M 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
238000002953 preparative HPLC Methods 0.000 description 1
238000012746 preparative thin layer chromatography Methods 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
230000009696 proliferative response Effects 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
VVWRJUBEIPHGQF-MDZDMXLPSA-N propan-2-yl (ne)-n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)\N=N\C(=O)OC(C)C VVWRJUBEIPHGQF-MDZDMXLPSA-N 0.000 description 1
TVQKIQLKLBBBBU-UHFFFAOYSA-N propan-2-yl 2-[1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-6-fluoro-3-propan-2-yloxyquinoline-4-carboxylate Chemical compound N=1C2=CC=C(F)C=C2C(C(=O)OC(C)C)=C(OC(C)C)C=1C(C)NC1=NC=NC(N)=C1C#N TVQKIQLKLBBBBU-UHFFFAOYSA-N 0.000 description 1
230000000069 prophylactic effect Effects 0.000 description 1
125000006225 propoxyethyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
235000013772 propylene glycol Nutrition 0.000 description 1
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
125000004548 quinolin-3-yl group Chemical group N1=CC(=CC2=CC=CC=C12)* 0.000 description 1
RYGIHSLRMNXWCN-UHFFFAOYSA-N quinoline-3-carbaldehyde Chemical compound C1=CC=CC2=CC(C=O)=CN=C21 RYGIHSLRMNXWCN-UHFFFAOYSA-N 0.000 description 1
DJXNJVFEFSWHLY-UHFFFAOYSA-N quinoline-3-carboxylic acid Chemical compound C1=CC=CC2=CC(C(=O)O)=CN=C21 DJXNJVFEFSWHLY-UHFFFAOYSA-N 0.000 description 1
VQMSRUREDGBWKT-UHFFFAOYSA-N quinoline-4-carboxylic acid Chemical compound C1=CC=C2C(C(=O)O)=CC=NC2=C1 VQMSRUREDGBWKT-UHFFFAOYSA-N 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
102000016914 ras Proteins Human genes 0.000 description 1
108010014186 ras Proteins Proteins 0.000 description 1
102000005962 receptors Human genes 0.000 description 1
108020003175 receptors Proteins 0.000 description 1
238000003259 recombinant expression Methods 0.000 description 1
210000000664 rectum Anatomy 0.000 description 1
238000006268 reductive amination reaction Methods 0.000 description 1
230000019254 respiratory burst Effects 0.000 description 1
208000023504 respiratory system disease Diseases 0.000 description 1
230000004043 responsiveness Effects 0.000 description 1
230000022932 ruffle assembly Effects 0.000 description 1
229940081969 saccharomyces cerevisiae Drugs 0.000 description 1
229960004889 salicylic acid Drugs 0.000 description 1
230000007017 scission Effects 0.000 description 1
CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
230000028327 secretion Effects 0.000 description 1
238000013207 serial dilution Methods 0.000 description 1
239000008159 sesame oil Substances 0.000 description 1
235000011803 sesame oil Nutrition 0.000 description 1
239000000741 silica gel Substances 0.000 description 1
229910002027 silica gel Inorganic materials 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
208000000587 small cell lung carcinoma Diseases 0.000 description 1
AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 1
239000000661 sodium alginate Substances 0.000 description 1
235000010413 sodium alginate Nutrition 0.000 description 1
229940005550 sodium alginate Drugs 0.000 description 1
URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
235000017557 sodium bicarbonate Nutrition 0.000 description 1
229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
235000010288 sodium nitrite Nutrition 0.000 description 1
239000012453 solvate Substances 0.000 description 1
241000894007 species Species 0.000 description 1
210000004988 splenocyte Anatomy 0.000 description 1
239000007921 spray Substances 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
239000008117 stearic acid Substances 0.000 description 1
230000001954 sterilising effect Effects 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
238000000859 sublimation Methods 0.000 description 1
230000008022 sublimation Effects 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
239000001384 succinic acid Substances 0.000 description 1
239000000375 suspending agent Substances 0.000 description 1
239000003765 sweetening agent Substances 0.000 description 1
239000000454 talc Substances 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
230000008685 targeting Effects 0.000 description 1
239000011975 tartaric acid Substances 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1
229940095064 tartrate Drugs 0.000 description 1
UNPZDJBBMURTBJ-AWEZNQCLSA-N tert-butyl 4-[[2-[(1s)-1-aminoethyl]-6-fluoro-4-methoxyquinolin-3-yl]methyl]piperazine-1-carboxylate Chemical compound C[C@H](N)C1=NC2=CC=C(F)C=C2C(OC)=C1CN1CCN(C(=O)OC(C)(C)C)CC1 UNPZDJBBMURTBJ-AWEZNQCLSA-N 0.000 description 1
RYQFDMMWLDIXOV-IBGZPJMESA-N tert-butyl 4-[[6-fluoro-4-methoxy-2-[(1s)-1-[(2-methoxycarbonylbenzoyl)amino]ethyl]quinolin-3-yl]methyl]piperazine-1-carboxylate Chemical compound COC(=O)C1=CC=CC=C1C(=O)N[C@@H](C)C1=NC2=CC=C(F)C=C2C(OC)=C1CN1CCN(C(=O)OC(C)(C)C)CC1 RYQFDMMWLDIXOV-IBGZPJMESA-N 0.000 description 1
CWXPZXBSDSIRCS-UHFFFAOYSA-N tert-butyl piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCNCC1 CWXPZXBSDSIRCS-UHFFFAOYSA-N 0.000 description 1
BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 1
125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
WHRNULOCNSKMGB-UHFFFAOYSA-N tetrahydrofuran thf Chemical compound C1CCOC1.C1CCOC1 WHRNULOCNSKMGB-UHFFFAOYSA-N 0.000 description 1
OSBSFAARYOCBHB-UHFFFAOYSA-N tetrapropylammonium Chemical compound CCC[N+](CCC)(CCC)CCC OSBSFAARYOCBHB-UHFFFAOYSA-N 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 description 1
150000003573 thiols Chemical class 0.000 description 1
229960004072 thrombin Drugs 0.000 description 1
230000002537 thrombolytic effect Effects 0.000 description 1
230000001732 thrombotic effect Effects 0.000 description 1
230000002992 thymic effect Effects 0.000 description 1
201000002510 thyroid cancer Diseases 0.000 description 1
208000013077 thyroid gland carcinoma Diseases 0.000 description 1
238000003354 tissue distribution assay Methods 0.000 description 1
JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
101150049389 tor2 gene Proteins 0.000 description 1
125000005490 tosylate group Chemical group 0.000 description 1
231100000027 toxicology Toxicity 0.000 description 1
238000013518 transcription Methods 0.000 description 1
230000035897 transcription Effects 0.000 description 1
230000009261 transgenic effect Effects 0.000 description 1
229940086542 triethylamine Drugs 0.000 description 1
150000008648 triflates Chemical group 0.000 description 1
125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 1
125000000025 triisopropylsilyl group Chemical group C(C)(C)[Si](C(C)C)(C(C)C)* 0.000 description 1
125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
210000003606 umbilical vein Anatomy 0.000 description 1
ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 description 1
208000010570 urinary bladder carcinoma Diseases 0.000 description 1
230000007054 vacuolar protein processing Effects 0.000 description 1
238000010200 validation analysis Methods 0.000 description 1
235000012141 vanillin Nutrition 0.000 description 1
MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
230000003612 virological effect Effects 0.000 description 1
239000011534 wash buffer Substances 0.000 description 1
238000009736 wetting Methods 0.000 description 1
238000010626 work up procedure Methods 0.000 description 1